Davide Capodanno
#118,896
Most Influential Person Now
Researcher
Davide Capodanno's AcademicInfluence.com Rankings
Davide Capodannocomputer-science Degrees
Computer Science
#4724
World Rank
#4987
Historical Rank
Machine Learning
#1025
World Rank
#1040
Historical Rank
Artificial Intelligence
#1248
World Rank
#1271
Historical Rank
Database
#1929
World Rank
#2024
Historical Rank
Download Badge
Computer Science
Davide Capodanno's Degrees
- PhD Computer Science University of Milan
Similar Degrees You Can Earn
Why Is Davide Capodanno Influential?
(Suggest an Edit or Addition)Davide Capodanno's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. (2020) (3083)
- Incidence and Predictors of Early and Late Mortality After Transcatheter Aortic Valve Implantation in 663 Patients With Severe Aortic Stenosis (2011) (1107)
- 2021 ESC/EACTS Guidelines for the management of valvular heart disease. (2021) (993)
- 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. (2021) (961)
- Incidence, predictors, and outcomes of aortic regurgitation after transcatheter aortic valve replacement: meta-analysis and systematic review of literature. (2013) (692)
- Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology Working Group on Thrombosis, European Heart Rhythm Association (2014) (550)
- 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. (2016) (529)
- Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes from the European multicentre GHOST-EU registry. (2015) (441)
- Clinical use of intracoronary imaging. Part 1: guidance and optimization of coronary interventions. An expert consensus document of the European Association of Percutaneous Cardiovascular Interventions (2018) (360)
- Standardized definitions of structural deterioration and valve failure in assessing long-term durability of transcatheter and surgical aortic bioprosthetic valves: a consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) endorsed by the European Societ (2017) (321)
- Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary Intervention (2019) (293)
- Transcatheter aortic valve implantation: 3-year outcomes of self-expanding CoreValve prosthesis. (2012) (291)
- An EAPCI Expert Consensus Document on Ischaemia with Non-Obstructive Coronary Arteries in Collaboration with European Society of Cardiology Working Group on Coronary Pathophysiology & Microcirculation Endorsed by Coronary Vasomotor Disorders International Study Group. (2020) (278)
- Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for High Bleeding Risk (2019) (266)
- Durability of Transcatheter and Surgical Bioprosthetic Aortic Valves in Patients at Lower Surgical Risk. (2019) (238)
- Percutaneous mitral valve repair with the MitraClip system: acute results from a real world setting (2010) (235)
- Dual antiplatelet therapy versus aspirin alone in patients undergoing transcatheter aortic valve implantation. (2011) (235)
- Usefulness of the SYNTAX Score for Predicting Clinical Outcome After Percutaneous Coronary Intervention of Unprotected Left Main Coronary Artery Disease (2009) (231)
- Platelet thrombin receptor antagonism and atherothrombosis (2009) (226)
- ACC/AHA Versus ESC Guidelines on Dual Antiplatelet Therapy: JACC Guideline Comparison. (2018) (223)
- Percutaneous coronary intervention versus coronary artery bypass graft surgery in left main coronary artery disease: a meta-analysis of randomized clinical data. (2011) (201)
- Are propensity scores really superior to standard multivariable analysis? (2011) (200)
- Impact of chronic kidney disease on platelet function profiles in diabetes mellitus patients with coronary artery disease taking dual antiplatelet therapy. (2010) (199)
- Pharmacodynamic Effects of Different Aspirin Dosing Regimens in Type 2 Diabetes Mellitus Patients With Coronary Artery Disease (2011) (191)
- Morphine Is Associated With a Delayed Activity of Oral Antiplatelet Agents in Patients With ST-Elevation Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention (2014) (181)
- Usefulness of SYNTAX score to select patients with left main coronary artery disease to be treated with coronary artery bypass graft. (2009) (175)
- 2021 ESC/EACTS Guidelines for the management of valvular heart disease: Developed by the Task Force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). (2022) (173)
- Clinical Outcomes Following Intravascular Imaging-Guided Versus Coronary Angiography-Guided Percutaneous Coronary Intervention With Stent Implantation: A Systematic Review and Bayesian Network Meta-Analysis of 31 Studies and 17,882 Patients. (2017) (163)
- Revisiting Sex Equality With Transcatheter Aortic Valve Replacement Outcomes: A Collaborative, Patient-Level Meta-Analysis of 11,310 Patients. (2015) (159)
- Aspirin-free strategies in cardiovascular disease and cardioembolic stroke prevention (2018) (156)
- Contemporary practice and technical aspects in coronary intervention with bioresorbable scaffolds: a European perspective. (2015) (153)
- Drug-eluting stent for left main coronary artery disease. The DELTA registry: a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment. (2012) (139)
- Global risk classification and clinical SYNTAX (synergy between percutaneous coronary intervention with TAXUS and cardiac surgery) score in patients undergoing percutaneous or surgical left main revascularization. (2011) (137)
- Standardized definitions of structural deterioration and valve failure in assessing long-term durability of transcatheter and surgical aortic bioprosthetic valves: a consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) endorsed by the European Societ (2017) (134)
- A simple risk tool (the OBSERVANT score) for prediction of 30-day mortality after transcatheter aortic valve replacement. (2014) (131)
- One- and twelve-month safety and efficacy outcomes of patients undergoing edge-to-edge percutaneous mitral valve repair (from the GRASP Registry). (2013) (129)
- Prevalence, predictors, and long-term prognosis of premature discontinuation of oral antiplatelet therapy after drug eluting stent implantation. (2011) (128)
- 2021 ESC/EACTS Guidelines for the management of valvular heart disease. (2021) (124)
- EuroSCORE refines the predictive ability of SYNTAX score in patients undergoing left main percutaneous coronary intervention. (2010) (124)
- Clinical use of intracoronary imaging. Part 2: acute coronary syndromes, ambiguous coronary angiography findings, and guiding interventional decision-making: an expert consensus document of the European Association of Percutaneous Cardiovascular Interventions. (2019) (123)
- Antithrombotic therapy in the elderly. (2010) (122)
- Association of tricuspid regurgitation with clinical and echocardiographic outcomes after percutaneous mitral valve repair with the MitraClip System: 30-day and 12-month follow-up from the GRASP Registry. (2014) (117)
- Antithrombotic Therapy in Patients With Chronic Kidney Disease (2012) (117)
- Predilation, sizing and post-dilation scoring in patients undergoing everolimus-eluting bioresorbable scaffold implantation for prediction of cardiac adverse events: development and internal validation of the PSP score. (2017) (111)
- Management of Antithrombotic Therapy in Atrial Fibrillation Patients Undergoing PCI: JACC State-of-the-Art Review. (2019) (111)
- Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement: A Systematic Review and Meta-analysis. (2016) (109)
- Mechanisms, pathophysiology, and clinical aspects of incomplete stent apposition. (2014) (108)
- Transcatheter Aortic Valve Implantation With or Without Percutaneous Coronary Artery Revascularization Strategy: A Systematic Review and Meta‐Analysis (2017) (104)
- Novel oral anticoagulants versus warfarin in non-valvular atrial fibrillation: a meta-analysis of 50,578 patients. (2013) (104)
- Validation of the Academic Research Consortium High Bleeding Risk Definition in Contemporary PCI Patients. (2020) (104)
- Impact of a decreasing pre-test probability on the performance of diagnostic tests for coronary artery disease. (2019) (103)
- Perioperative management of antiplatelet therapy in patients with coronary stents undergoing cardiac and non-cardiac surgery: a consensus document from Italian cardiological, surgical and anaesthesiological societies. (2014) (103)
- Quality of life assessment after percutaneous aortic valve implantation. (2009) (102)
- Extended use of percutaneous edge-to-edge mitral valve repair beyond EVEREST (Endovascular Valve Edge-to-Edge Repair) criteria: 30-day and 12-month clinical and echocardiographic outcomes from the GRASP (Getting Reduction of Mitral Insufficiency by Percutaneous Clip Implantation) registry. (2015) (101)
- Treatment strategies for coronary in-stent restenosis: systematic review and hierarchical Bayesian network meta-analysis of 24 randomised trials and 4880 patients (2015) (100)
- Acute Kidney Injury With the RenalGuard System in Patients Undergoing Transcatheter Aortic Valve Replacement: The PROTECT-TAVI Trial (PROphylactic effecT of furosEmide-induCed diuresis with matched isotonic intravenous hydraTion in Transcatheter Aortic Valve Implantation). (2015) (99)
- Clinical use of intracoronary imaging. Part 1: guidance and optimization of coronary interventions. An expert consensus document of the European Association of Percutaneous Cardiovascular Interventions. (2018) (95)
- Coronavirus Disease 2019–Associated Thrombosis and Coagulopathy: Review of the Pathophysiological Characteristics and Implications for Antithrombotic Management (2020) (93)
- Aspirin for Primary Cardiovascular Risk Prevention and Beyond in Diabetes Mellitus (2016) (92)
- Radial Access Reduces Mortality in Patients With Acute Coronary Syndromes: Results From an Updated Trial Sequential Analysis of Randomized Trials. (2016) (90)
- Eroded Versus Ruptured Plaques at the Culprit Site of STEMI: In Vivo Pathophysiological Features and Response to Primary PCI. (2015) (90)
- Management of Antiplatelet Therapy in Patients With Coronary Artery Disease Requiring Cardiac and Noncardiac Surgery (2013) (90)
- Mechanisms of atherothrombosis and vascular response to primary percutaneous coronary intervention in women versus men with acute myocardial infarction: results of the OCTAVIA study. (2014) (89)
- Predictors of clinical outcomes after edge-to-edge percutaneous mitral valve repair. (2015) (88)
- Self-expanding versus balloon-expandable stents in acute myocardial infarction: results from the APPOSITION II study: self-expanding stents in ST-segment elevation myocardial infarction. (2012) (88)
- Procedural success and 30-day clinical outcomes after percutaneous aortic valve replacement using current third-generation self-expanding CoreValve prosthesis. (2009) (82)
- Early Conduction Disorders Following Percutaneous Aortic Valve Replacement (2009) (82)
- Radial Versus Femoral Access in Invasively Managed Patients With Acute Coronary Syndrome (2015) (82)
- Early discharge after transfemoral transcatheter aortic valve implantation (2015) (80)
- Mechanism of action and clinical development of ticagrelor, a novel platelet ADP P2Y12 receptor antagonist (2010) (79)
- Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary artery: the DELTA Registry (drug-eluting stent for left main coronary artery disease): a multicenter registry evaluating percutaneous (2013) (78)
- Validation of high bleeding risk criteria and definition as proposed by the academic research consortium for high bleeding risk. (2020) (77)
- ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2—care pathways, treatment, and follow-up (2021) (77)
- Local delivery versus intracoronary infusion of abciximab in patients with acute coronary syndromes. (2010) (75)
- Guided versus standard antiplatelet therapy in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis (2021) (75)
- Derivation, Validation, and Prognostic Utility of a Prediction Rule for Nonresponse to Clopidogrel: The ABCD-GENE Score. (2020) (72)
- Clinical use of intracoronary imaging. Part 2: acute coronary syndromes, ambiguous coronary angiography findings, and guiding interventional decision-making: an expert consensus document of the European Association of Percutaneous Cardiovascular Interventions. (2019) (71)
- Incidence of Long‐Term Structural Valve Dysfunction and Bioprosthetic Valve Failure After Transcatheter Aortic Valve Replacement (2018) (69)
- Impact of race and gender on antithrombotic therapy (2010) (69)
- Impact of postoperative acute kidney injury on clinical outcomes after transcatheter aortic valve implantation: A meta‐analysis of 5,971 patients (2015) (69)
- Long-term outcomes of patients with acute coronary syndrome and nonobstructive coronary artery disease. (2013) (68)
- Management of Antiplatelet and Anticoagulant Therapy in Patients With Atrial Fibrillation in the Setting of Acute Coronary Syndromes or Percutaneous Coronary Interventions (2014) (66)
- Incidence rate and predictors of permanent pacemaker implantation after transcatheter aortic valve implantation with self-expanding CoreValve prosthesis (2012) (66)
- Balloon aortic valvuloplasty for severe aortic stenosis as a bridge to high-risk transcatheter aortic valve implantation. (2010) (66)
- Bivalirudin versus heparin with or without glycoprotein IIb/IIIa inhibitors in patients with STEMI undergoing primary PCI: An updated meta-analysis of 10,350 patients from five randomized clinical trials (2016) (65)
- Antiplatelet therapy: new pharmacological agents and changing paradigms (2013) (65)
- Meta-analysis of randomized controlled trials and adjusted observational results of use of clopidogrel, aspirin, and oral anticoagulants in patients undergoing percutaneous coronary intervention. (2015) (64)
- Transcatheter aortic valve implantation in 2017: state of the art. (2017) (63)
- Current use of intracoronary imaging in interventional practice - Results of a European Association of Percutaneous Cardiovascular Interventions (EAPCI) and Japanese Association of Cardiovascular Interventions and Therapeutics (CVIT) Clinical Practice Survey. (2018) (63)
- Corrigendum to: 2021 ESC/EACTS Guidelines for the management of valvular heart disease. (2022) (63)
- A Multidisciplinary Approach on the Perioperative Antithrombotic Management of Patients With Coronary Stents Undergoing Surgery: Surgery After Stenting 2. (2018) (62)
- Moderate and Severe Preoperative Chronic Kidney Disease Worsen Clinical Outcomes After Transcatheter Aortic Valve Implantation: Meta-Analysis of 4992 Patients (2015) (62)
- Comparison of complications and outcomes to one year of transcatheter aortic valve implantation versus surgical aortic valve replacement in patients with severe aortic stenosis. (2012) (62)
- Comparison of optical coherence tomography and intravascular ultrasound for the assessment of in-stent tissue coverage after stent implantation. (2009) (61)
- Pharmacodynamic Effects of Concomitant Versus Staggered Clopidogrel and Omeprazole Intake: Results of a Prospective Randomized Crossover Study (2010) (60)
- Impact of insulin receptor substrate-1 genotypes on platelet reactivity and cardiovascular outcomes in patients with type 2 diabetes mellitus and coronary artery disease. (2011) (59)
- Report of an ESC-EAPCI Task Force on the evaluation and use of bioresorbable scaffolds for percutaneous coronary intervention: executive summary (2018) (59)
- Dual-pathway inhibition for secondary and tertiary antithrombotic prevention in cardiovascular disease (2020) (58)
- Preventive Strategies for Contrast-Induced Acute Kidney Injury in Patients Undergoing Percutaneous Coronary Procedures: Evidence From a Hierarchical Bayesian Network Meta-Analysis of 124 Trials and 28 240 Patients (2017) (58)
- Pretreatment With Antiplatelet Drugs in Invasively Managed Patients With Coronary Artery Disease in the Contemporary Era: Review of the Evidence and Practice Guidelines (2015) (58)
- Management of implant failure during transcatheter aortic valve implantation (2010) (57)
- Are drug-eluting stents superior to bare-metal stents in patients with unprotected non-bifurcational left main disease? Insights from a multicentre registry. (2009) (54)
- Updating the evidence on patent foramen ovale closure versus medical therapy in patients with cryptogenic stroke: a systematic review and comprehensive meta-analysis of 2,303 patients from three randomised trials and 2,231 patients from 11 observational studies. (2014) (54)
- Left main coronary artery disease: pathophysiology, diagnosis, and treatment (2018) (54)
- Short dual antiplatelet therapy followed by P2Y12 inhibitor monotherapy vs. prolonged dual antiplatelet therapy after percutaneous coronary intervention with second-generation drug-eluting stents: a systematic review and meta-analysis of randomized clinical trials. (2020) (54)
- Quality-of-life in elderly patients one year after transcatheter aortic valve implantation for severe aortic stenosis. (2011) (52)
- Comparison of Self-Expanding Bioprostheses for Transcatheter Aortic Valve Replacement in Patients With Symptomatic Severe Aortic Stenosis (2020) (52)
- Antiplatelet Therapy After Implantation of Bioresorbable Vascular Scaffolds: A Review of the Published Data, Practical Recommendations, and Future Directions. (2017) (52)
- Cigarette smoking is associated with a dose-response effect in clopidogrel-treated patients with diabetes mellitus and coronary artery disease: results of a pharmacodynamic study. (2012) (50)
- [2021 ESC Guidelines on cardiovascular disease prevention in clinical practice]. (2022) (50)
- Cardiac arrhythmias in the emergency settings of acute coronary syndrome and revascularization: an European Heart Rhythm Association (EHRA) consensus document, endorsed by the European Association of Percutaneous Cardiovascular Interventions (EAPCI), and European Acute Cardiovascular Care Associatio (2019) (49)
- Meta-analysis of randomized controlled trials of preprocedural statin administration for reducing contrast-induced acute kidney injury in patients undergoing coronary catheterization. (2014) (49)
- ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2—care pathways, treatment, and follow-up (2021) (49)
- Late thrombotic events after bioresorbable scaffold implantation: a systematic review and meta-analysis of randomized clinical trials (2017) (49)
- Thrombotic Versus Bleeding Risk After Transcatheter Aortic Valve Replacement: JACC Review Topic of the Week. (2019) (47)
- Prognostic indicators for recurrent thrombotic events in HIV-infected patients with acute coronary syndromes: use of registry data from 12 sites in Europe, South Africa and the United States. (2014) (45)
- Real-world outcome of coronary bifurcation lesions in the drug-eluting stent era: results from the 4,314-patient Italian Society of Invasive Cardiology (SICI-GISE) Italian Multicenter Registry on Bifurcations (I-BIGIS). (2010) (44)
- Perioperative management of oral antiplatelet therapy and clinical outcomes in coronary stent patients undergoing surgery (2014) (44)
- Imaging in ESC clinical guidelines: chronic coronary syndromes. (2019) (44)
- Impact of balloon post-dilation on clinical outcomes after transcatheter aortic valve replacement with the self-expanding CoreValve prosthesis. (2014) (44)
- Tailoring duration of DAPT with risk scores (2017) (44)
- Haemostatic profiles assessed by thromboelastography in patients with end-stage renal disease (2011) (44)
- Comparison of one-year outcomes of percutaneous coronary intervention versus coronary artery bypass grafting in patients with unprotected left main coronary artery disease and acute coronary syndromes (from the CUSTOMIZE Registry). (2011) (43)
- Effect of renal artery stenting on left ventricular mass: a randomized clinical trial. (2012) (43)
- Integrating the Synergy between percutaneous coronary intervention with Taxus and Cardiac Surgery (SYNTAX) score into practice: use, pitfalls, and new directions. (2011) (43)
- Comparison of suture-based vascular closure devices in transfemoral transcatheter aortic valve implantation. (2015) (42)
- Functional profile of the platelet P2Y12 receptor signalling pathway in patients with type 2 diabetes mellitus and coronary artery disease (2011) (42)
- Cardiovascular magnetic resonance for the assessment of patients undergoing transcatheter aortic valve implantation: a pilot study (2011) (42)
- European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1—epidemiology, pathophysiology, and diagnosis (2021) (42)
- Predictive accuracy of CHA2DS2-VASc and HAS-BLED scores in patients without atrial fibrillation undergoing percutaneous coronary intervention and discharged on dual antiplatelet therapy. (2015) (42)
- Clinical, Angiographic, Functional, and Imaging Outcomes 12 Months After Implantation of Drug-Eluting Bioresorbable Vascular Scaffolds in Acute Coronary Syndromes. (2015) (42)
- Safety and efficacy of different prophylactic anticoagulation dosing regimens in critically and non-critically ill patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials (2021) (41)
- Plaque distribution patterns in distal left main coronary artery to predict outcomes after stent implantation. (2010) (41)
- Impact of gene polymorphisms, platelet reactivity, and the SYNTAX score on 1-year clinical outcomes in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention: the GEPRESS study. (2014) (40)
- First-in-man 1-year clinical outcomes of the Catania Coronary Stent System with Nanothin Polyzene-F in de novo native coronary artery lesions: the ATLANTA (Assessment of The LAtest Non-Thrombogenic Angioplasty stent) trial. (2009) (40)
- Is intravascular ultrasound beneficial for percutaneous coronary intervention of bifurcation lesions? Evidence from a 4,314-patient registry (2011) (40)
- Gender‐related clinical and echocardiographic outcomes at 30‐day and 12‐month follow up after MitraClip implantation in the GRASP registry (2015) (40)
- Temporal course of vascular healing and neoatherosclerosis after implantation of durable- or biodegradable-polymer drug-eluting stents (2018) (39)
- Left ventricular reverse remodeling after transcatheter aortic valve implantation: a cardiovascular magnetic resonance study (2013) (39)
- Aspirin Desensitization in Patients With Coronary Artery Disease: Results of the Multicenter ADAPTED Registry (Aspirin Desensitization in Patients With Coronary Artery Disease) (2017) (39)
- Prognostically relevant periprocedural myocardial injury and infarction associated with percutaneous coronary interventions: a Consensus Document of the ESC Working Group on Cellular Biology of the Heart and European Association of Percutaneous Cardiovascular Interventions (EAPCI) (2021) (39)
- Five-year clinical outcomes after percutaneous edge-to-edge mitral valve repair: Insights from the multicenter GRASP-IT registry. (2019) (39)
- Early‐ and mid‐term outcomes of transcatheter aortic valve implantation in patients with logistic EuroSCORE less than 20%: A comparative analysis between different risk strata (2012) (39)
- Intravenous antiplatelet therapies (glycoprotein IIb/IIIa receptor inhibitors and cangrelor) in percutaneous coronary intervention: from pharmacology to indications for clinical use (2019) (38)
- Safety and Efficacy of Double Antithrombotic Therapy With Non–Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta‐Analysis (2020) (38)
- Pharmacodynamic Evaluation of Pantoprazole Therapy on Clopidogrel Effects: Results of a Prospective, Randomized, Crossover Study (2011) (38)
- Objectifying the impact of incomplete revascularization by repeat angiographic risk assessment with the residual SYNTAX score after left main coronary artery percutaneous coronary intervention (2013) (38)
- Impact of adjunctive cilostazol therapy on platelet function profiles in patients with and without diabetes mellitus on aspirin and clopidogrel therapy (2011) (38)
- Real-world cost effectiveness of MitraClip combined with Medical Therapy Versus Medical therapy alone in patients with moderate or severe mitral regurgitation. (2016) (37)
- Spontaneous coronary artery dissection. (1998) (37)
- Mini-crush versus T-provisional techniques in bifurcation lesions: clinical and angiographic long-term outcome after implantation of drug-eluting stents. (2009) (37)
- Long-term clinical outcomes after percutaneous coronary intervention versus coronary artery bypass grafting for ostial/midshaft lesions in unprotected left main coronary artery from the DELTA registry: a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass (2014) (37)
- State of the art: duration of dual antiplatelet therapy after percutaneous coronary intervention and coronary stent implantation - past, present and future perspectives. (2017) (36)
- Guía ESC 2015 sobre el tratamiento de pacientes con arritmiasventriculares y prevención de la muerte súbita cardiaca (2016) (36)
- Bleeding avoidance strategies in percutaneous coronary intervention (2021) (36)
- Early and midterm outcomes of bioresorbable vascular scaffolds for ostial coronary lesions: insights from the GHOST-EU registry. (2016) (36)
- Anatomical features and management of bioresorbable vascular scaffolds failure: A case series from the GHOST registry (2015) (36)
- Impact of the COVID-19 pandemic on interventional cardiology practice: results of the EAPCI survey. (2020) (36)
- The DELTA 2 Registry: A Multicenter Registry Evaluating Percutaneous Coronary Intervention With New-Generation Drug-Eluting Stents in Patients With Obstructive Left Main Coronary Artery Disease. (2017) (36)
- Safety and efficacy of protease‐activated receptor‐1 antagonists in patients with coronary artery disease: a meta‐analysis of randomized clinical trials (2012) (35)
- 2021 ESC/EACTS Guidelines for the management of valvular heart disease. (2021) (35)
- Antithrombotic treatment in patients undergoing transcatheter aortic valve implantation (TAVI) (2015) (34)
- Are the culprit lesions severely stenotic? (2013) (33)
- Stroke After Coronary Artery Bypass Grafting and Percutaneous Coronary Intervention: Incidence, Pathogenesis, and Outcomes (2019) (33)
- Safety of clopidogrel and proton pump inhibitors in patients undergoing drug-eluting stent implantation (2011) (33)
- Comparison of three contemporary surgical scores for predicting all-cause mortality of patients undergoing percutaneous mitral valve repair with the MitraClip system (from the multicenter GRASP-IT registry). (2015) (33)
- Assessing the Risks of Bleeding vs Thrombotic Events in Patients at High Bleeding Risk After Coronary Stent Implantation: The ARC-High Bleeding Risk Trade-off Model. (2021) (33)
- Usefulness and validation of the survival posT TAVI score for survival after transcatheter aortic valve implantation for aortic stenosis. (2014) (33)
- Comparison of drug-eluting stents and bare-metal stents for the treatment of unprotected left main coronary artery disease in acute coronary syndromes. (2009) (32)
- An EAPCI Expert Consensus Document on Ischaemia with Non-Obstructive Coronary Arteries in Collaboration with European Society of Cardiology Working Group on Coronary Pathophysiology & Microcirculation Endorsed by Coronary Vasomotor Disorders International Study Group. (2020) (32)
- Short Duration of DAPT Versus De-Escalation After Percutaneous Coronary Intervention for Acute Coronary Syndromes. (2022) (32)
- Impact of Clinical Presentation on Bleeding Risk after Percutaneous Coronary Intervention and Implications for the ARC-HBR Definition. (2021) (32)
- Percutaneous recanalization of chronic total occlusions: wherein lies the body of proof? (2013) (31)
- Assessing Risk in Patients with Stable Coronary Disease: When Should We Intensify Care and Follow-Up? Results from a Meta-Analysis of Observational Studies of the COURAGE and FAME Era (2016) (31)
- Management of left main disease: an update. (2019) (31)
- Meta-Analyses of Dual Antiplatelet Therapy Following Drug-Eluting Stent Implantation: Do Bleeding and Stent Thrombosis Weigh Similar on Mortality? (2015) (30)
- Prognostic value of exercise myocardial scintigraphy in patients with coronary chronic total occlusions. (2010) (30)
- Serial Assessment of Coronary Artery Response to Paclitaxel-Eluting Stents Using Optical Coherence Tomography (2012) (30)
- Platelet function profiles in the elderly: Results of a pharmacodynamic study in patients on clopidogrel therapy and effects of switching to prasugrel 5 mg in patients with high platelet reactivity (2011) (30)
- Residual platelet reactivity to predict long-term clinical outcomes after clopidogrel loading in patients with acute coronary syndromes: comparison of different cutoff values by light transmission aggregometry from the responsiveness to clopidogrel and stent thrombosis 2-acute coronary syndrome (REC (2015) (30)
- Early, late and very late incidence of bioresorbable scaffold thrombosis: a systematic review and meta-analysis of randomized clinical trials and observational studies. (2017) (29)
- Novel drug-eluting stents in the treatment of de novo coronary lesions (2011) (29)
- 1-Year Outcomes of Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Stents: A Propensity-Matched Comparison of the GHOST-EU and XIENCE V USA Registries. (2016) (29)
- Risk prediction of contrast-induced nephropathy by ACEF score in patients undergoing coronary catheterization (2016) (29)
- Validating the EXCEL hypothesis: A propensity score matched 3‐year comparison of percutaneous coronary intervention versus coronary artery bypass graft in left main patients with SYNTAX score ≤32 (2011) (29)
- Computing Methods for Composite Clinical Endpoints in Unprotected Left Main Coronary Artery Revascularization: A Post Hoc Analysis of the DELTA Registry. (2016) (28)
- Optimized Screening of Coronary Artery Disease With Invasive Coronary Angiography and Ad Hoc Percutaneous Coronary Intervention During Transcatheter Aortic Valve Replacement (2017) (28)
- A Risk Model for Prediction of 1-Year Mortality in Patients Undergoing MitraClip Implantation. (2017) (28)
- Bioresorbable vascular scaffold use for coronary bifurcation lesions: A substudy from GHOST EU registry (2017) (28)
- Effects of statins on plaque rupture assessed by optical coherence tomography in patients presenting with acute coronary syndromes: insights from the optical coherence tomography (OCT)-FORMIDABLE registry (2018) (28)
- At the peak of Covid-19 age and disease severity but not comorbidities are predictors of mortality. Covid-19 burden in Bergamo, Italy. (2020) (27)
- Effects of cangrelor in coronary artery disease patients with and without diabetes mellitus: an in vitro pharmacodynamic investigation (2013) (27)
- Impact of different stent alloys on human vascular response to everolimus‐eluting stent: An optical coherence tomography study: The OCTEVEREST (2013) (26)
- Incorporating glomerular filtration rate or creatinine clearance by the modification of diet in renal disease equation or the Cockcroft-Gault equations to improve the global accuracy of the Age, Creatinine, Ejection Fraction [ACEF] score in patients undergoing percutaneous coronary intervention. (2013) (25)
- Beyond the SYNTAX score--advantages and limitations of other risk assessment systems in left main percutaneous coronary intervention. (2013) (25)
- Trial Design Principles for Patients at High Bleeding Risk Undergoing PCI: JACC Scientific Expert Panel. (2020) (25)
- Management of Myocardial Revascularization Failure: An Expert Consensus Document of the EAPCI. (2020) (25)
- Impact of chronic kidney disease on outcomes after percutaneous mitral valve repair with the MitraClip system: insights from the GRASP registry. (2016) (24)
- Ventricular arrhythmias in aortic valve stenosis before and after transcatheter aortic valve implantation. (2015) (24)
- Relationship between diabetes, platelet reactivity, and the SYNTAX score to one-year clinical outcome in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention. (2016) (24)
- What about the risk of thrombosis with bioresorbable scaffolds? (2015) (24)
- Unraveling the EXCEL: promises and challenges of the next trial of left main percutaneous coronary intervention. (2012) (24)
- Intraoperative defibrillation threshold testing during implantable cardioverter-defibrillator insertion: do we really need it? (2010) (24)
- Antithrombotic Therapy for Prevention of Cerebral Thromboembolic Events After Transcatheter Aortic Valve Replacement: Evolving Paradigms and Ongoing Directions. (2017) (23)
- Volumetric assessment of lesion severity with optical coherence tomography: relationship with fractional flow. (2013) (23)
- Updates on NSAIDs in patients with and without coronary artery disease: pitfalls, interactions and cardiovascular outcomes (2014) (23)
- Real world safety and efficacy of the Janus tacrolimus‐eluting stent: Long‐term clinical outcome and angiographic findings from the tacrolimus‐eluting stent (TEST) registry (2009) (23)
- Five-year outcomes of percutaneous coronary intervention versus coronary artery bypass graft surgery in patients with left main coronary artery disease: An updated meta-analysis of randomized trials and adjusted observational studies. (2015) (23)
- Optical coherence tomographic results at six-month follow-up evaluation of the CATANIA coronary stent system with nanothin Polyzene-F surface modification (from the Assessment of The LAtest Non-Thrombogenic Angioplasty Stent [ATLANTA] trial). (2009) (22)
- Safety and efficacy of non-vitamin K antagonist oral anticoagulants in elderly patients with atrial fibrillation. (2019) (22)
- Impact of Kissing Balloon in Patients Treated With Ultrathin Stents for Left Main Lesions and Bifurcations (2020) (22)
- The SYNTAX score on its way out or … towards artificial intelligence: part I. (2020) (22)
- Bleeding after antiplatelet therapy for the treatment of acute coronary syndromes: a review of the evidence and evolving paradigms (2019) (22)
- Transcatheter or surgical treatment of severe aortic stenosis and coronary artery disease: A comparative analysis from the Italian OBSERVANT study. (2018) (21)
- Percutaneous mitral valve repair with the MitraClip system for severe mitral regurgitation in patients with surgical mitral valve repair failure. (2014) (21)
- Volume‐to‐creatinine clearance ratio in patients undergoing coronary angiography with or without percutaneous coronary intervention: Implications of varying definitions of contrast‐induced nephropathy (2014) (21)
- Antithrombotic Therapy for Atherosclerotic Cardiovascular Disease Risk Mitigation in Patients With Coronary Artery Disease and Diabetes Mellitus (2020) (21)
- Selatogrel, a novel P2Y12 inhibitor: a review of the pharmacology and clinical development (2020) (21)
- Genetic testing in patients undergoing percutaneous coronary intervention: rationale, evidence and practical recommendations (2021) (21)
- Non-cardiac surgery in patients with coronary artery disease: risk evaluation and periprocedural management (2020) (21)
- Appraising the impact of left ventricular ejection fraction on outcomes of percutaneous drug-eluting stenting for unprotected left main disease: insights from a multicenter registry of 975 patients (2011) (21)
- Canakinumab for secondary prevention of atherosclerotic disease (2018) (20)
- Impact of bridging with perioperative low-molecular-weight heparin on cardiac and bleeding outcomes of stented patients undergoing non-cardiac surgery (2015) (20)
- Anticoagulation after Transcatheter Aortic Valve Implantation: Current Status (2019) (20)
- Risk Stratification in Patients with Coronary Artery Disease: A Practical Walkthrough in the Landscape of Prognostic Risk Models. (2018) (20)
- Triple antithrombotic therapy in atrial fibrillation patients with acute coronary syndromes or undergoing percutaneous coronary intervention or transcatheter aortic valve replacement. (2015) (20)
- New-onset atrial fibrillation and increased mortality after transcatheter aortic valve implantation: A causal or spurious association? (2016) (20)
- Positive airway pressure in patients with coronary artery disease and obstructive sleep apnea syndrome (2014) (20)
- Percutaneous closure of patent foramen ovale with a bioabsorbable occluder device (2009) (20)
- Antithrombotic Therapy After Transcatheter Aortic Valve Replacement. (2021) (20)
- Pharmacodynamic Evaluation of Pantoprazole Therapy on Clopidogrel EffectsClinical Perspective (2011) (20)
- Pharmacodynamic effects of adjunctive cilostazol therapy in patients with coronary artery disease on dual antiplatelet therapy: Impact of high on‐treatment platelet reactivity and diabetes mellitus status (2013) (19)
- Comparative one-year effectiveness of percutaneous coronary intervention versus coronary artery bypass grafting in patients <75 versus ≥75 years with unprotected left main disease (from the CUSTOMIZE Registry). (2012) (19)
- Percutaneous mitral valve repair with the MitraClip system in the elderly: One-year outcomes from the GRASP registry. (2016) (19)
- Current status and clinical development of transcatheter approaches for severe mitral regurgitation. (2015) (19)
- Does occlusion duration influence procedural and clinical outcome of patients who underwent percutaneous coronary intervention for chronic total occlusion? (2011) (19)
- Report of an ESC-EAPCI Task Force on the evaluation and use of bioresorbable scaffolds for percutaneous coronary intervention: executive summary. (2018) (19)
- Transesophageal echocardiography and transcranial color Doppler: independent or complementary diagnostic tests for cardiologists in the detection of patent foramen ovale? (2009) (19)
- Antiplatelet therapy and outcome in patients undergoing surgery following coronary stenting: Results of the surgery after stenting registry (2017) (19)
- Diagnostic pathways in myocardial infarction with non-obstructive coronary artery disease (MINOCA). (2021) (19)
- Aspirin for the primary prevention of cardiovascular disease: latest evidence (2019) (19)
- Long-term clinical outcomes after percutaneous coronary intervention versus coronary artery bypass grafting for acute coronary syndrome from the DELTA registry: a multicentre registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment. (2016) (19)
- Effectiveness of MitraClip therapy in patients with refractory heart failure. (2015) (18)
- Current Use of Intracoronary Imaging in Interventional Practice - Results of a European Association of Percutaneous Cardiovascular Interventions (EAPCI) and Japanese Association of Cardiovascular Interventions and Therapeutics (CVIT) Clinical Practice Survey. (2018) (18)
- Optical coherence tomography guided in-stent thrombus removal in patients with acute coronary syndromes (2013) (18)
- Long-term outcomes after drug-eluting stent for the treatment of ostial left anterior descending coronary artery lesions. (2010) (18)
- Antithrombotic therapy for secondary prevention of atherothrombotic events in cerebrovascular disease (2016) (18)
- CSL112, a reconstituted, infusible, plasma-derived apolipoprotein A-I: safety and tolerability profiles and implications for management in patients with myocardial infarction (2018) (18)
- Bivalirudin for acute coronary syndromes: premises, promises and doubts (2014) (17)
- Lessons from the GHOST-EU registry. (2015) (17)
- Paclitaxel versus sirolimus eluting stents in diabetic patients: Does stent type and/or stent diameter matter?: Long‐term clinical outcome of 2,429‐patient multicenter registry (2013) (17)
- ClearWayRX System to reduce intracoronary thrombus in patients with acute coronary syndromes according to Optical Coherence Tomography after Abciximab Intracoronary Local infusion trial (COCTAIL): study rationale and design (2010) (16)
- Gender differences on benefits and risks associated with oral antithrombotic medications for coronary artery disease (2018) (16)
- Impact of overlapping on 1‐year clinical outcomes in patients undergoing everolimus‐eluting bioresorbable scaffolds implantation in routine clinical practice: Insights from the European multicenter GHOST‐EU registry (2017) (16)
- Comparison of percutaneous coronary intervention (with drug-eluting stents) versus coronary artery bypass grafting in women with severe narrowing of the left main coronary artery (from the Women-Drug-Eluting stent for LefT main coronary Artery disease Registry). (2014) (16)
- Treatment of coronary bifurcation lesions with bioresorbable vascular scaffolds. (2014) (16)
- Impact of pentoxifylline on platelet function profiles in patients with type 2 diabetes mellitus and coronary artery disease on dual antiplatelet therapy with aspirin and clopidogrel. (2011) (16)
- High on-treatment platelet reactivity and outcome in elderly with non ST-segment elevation acute coronary syndrome - Insight from the GEPRESS study. (2018) (16)
- Impact of renal function on clopidogrel-induced antiplatelet effects in coronary artery disease patients without diabetes mellitus (2013) (16)
- Impact of Final Kissing Balloon and of Imaging on Patients Treated on Unprotected Left Main Coronary Artery With Thin-Strut Stents (From the RAIN-CARDIOGROUP VII Study). (2019) (16)
- Bioresorbable Scaffolds in Coronary Intervention: Unmet Needs and Evolution (2017) (16)
- Incidence, Timing, Causes and Predictors of Early and Late Re-Hospitalization in Patients Who Underwent Percutaneous Mitral Valve Repair With the MitraClip System. (2018) (15)
- Percutaneous coronary and structural interventions in women: a position statement from the EAPCI Women Committee. (2018) (15)
- Impact of residual platelet reactivity on reperfusion in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention (2016) (15)
- A novel 3-d reconstruction system for the assessment of bifurcation lesions treated by the mini-crush technique. (2010) (15)
- Risk Stratification for Bleeding in the Elderly with Acute Coronary Syndrome: Not So Simple (2018) (15)
- Meta-Analysis Comparing P2Y12 Inhibitors in Acute Coronary Syndrome. (2020) (15)
- Outcomes of renin–angiotensin–aldosterone system blockers in patients with COVID-19: a systematic review and meta-analysis (2020) (15)
- Cangrelor: Clinical Data, Contemporary Use, and Future Perspectives (2021) (15)
- Antithrombotic Therapy in Patients Undergoing Transcatheter Interventions for Structural Heart Disease (2021) (15)
- Triple Antithrombotic Therapy at the Intercept Between Threats and Opportunities: Don't Throw Out the Baby With the Bath Water. (2017) (15)
- Bioresorbable Everolimus-Eluting Vascular Scaffold for Long Coronary Lesions: A Subanalysis of the International, Multicenter GHOST-EU Registry. (2017) (15)
- A novel approach to define risk of stent thrombosis after percutaneous coronary intervention with drug-eluting stents: the DERIVATION score (2009) (14)
- Statistical primer: methodology and reporting of meta-analyses† (2018) (14)
- The SYNTAX score on its way out or … towards artificial intelligence: part II. (2020) (14)
- Gender-related differences of diabetic patients undergoing percutaneous coronary intervention with drug-eluting stents: a real-life multicenter experience. (2013) (14)
- Percutaneous Coronary Intervention Versus Coronary Artery Bypass Graft Surgery in Left Main Coronary Artery Disease (2011) (14)
- Usefulness of contrast injection during balloon aortic valvuloplasty before transcatheter aortic valve replacement: a pilot study. (2014) (14)
- EuroSCORE II versus additive and logistic EuroSCORE in patients undergoing percutaneous coronary intervention. (2013) (13)
- Incidence and potential mechanism of resolved, persistent and newly acquired malapposition three days after implantation of self-expanding or balloon-expandable stents in a STEMI population: insights from optical coherence tomography in the APPOSITION II study. (2015) (13)
- Neoatherosclerosis as the cause of late failure of a bioresorbable vascular scaffold. (2015) (13)
- Everolimus‐eluting bioresorbable vascular scaffolds versus second generation drug‐eluting stents for percutaneous treatment of chronic total coronary occlusions: Technical and procedural outcomes from the GHOST‐CTO registry (2016) (13)
- Roadmap Consensus on Carotid Artery Plaque Imaging and Impact on Therapy Strategies and Guidelines: An International, Multispecialty, Expert Review and Position Statement (2021) (13)
- Reviewing the controversy surrounding pre-treatment with P2Y12 inhibitors in acute coronary syndrome patients (2016) (13)
- Non-Hemodynamically Significant Renal Artery Stenosis Predicts Cardiovascular Events in Persons with Ischemic Heart Disease (2014) (13)
- Prediction of high on-treatment platelet reactivity in clopidogrel-treated patients with acute coronary syndromes. (2017) (13)
- Sex‐Based Differences in Bleeding Risk After Percutaneous Coronary Intervention and Implications for the Academic Research Consortium High Bleeding Risk Criteria (2021) (12)
- Prognostic implications of early and long‐term bleeding events in patients on one‐year dual antiplatelet therapy following drug‐eluting stent implantation (2012) (12)
- A multidisciplinary consensus document on follow‐up strategies for patients treated with percutaneous coronary intervention (2015) (12)
- Tailoring Antiplatelet Therapy in Patients Undergoing Transcatheter Aortic Valve Replacement: Navigating the Unknown. (2019) (12)
- Safety and efficacy of P2Y12 inhibitor monotherapy in patients undergoing percutaneous coronary interventions (2020) (12)
- The SYNTAX score does not predict presence of carotid disease in a multivessel coronary disease population (2014) (12)
- Impact of right coronary artery disease on mortality in patients undergoing percutaneous coronary intervention of unprotected left main coronary artery disease. (2010) (12)
- First-in-human description of everolimus-eluting bioabsorbable vascular scaffold implantation for the treatment of drug-eluting stent failure: insights from optical coherence tomography. (2013) (12)
- Antithrombotic Therapy after Percutaneous Coronary Intervention of Bifurcation Lesions. (2020) (12)
- European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1—epidemiology, pathophysiology, and diagnosis (2021) (12)
- Daily risk of adverse outcomes in patients undergoing complex lesions revascularization: A subgroup analysis from the RAIN-CARDIOGROUP VII study (veRy thin stents for patients with left mAIn or bifurcatioN in real life). (2019) (12)
- Platelet monitoring for PCI (2009) (12)
- Long-term follow-up after drug eluting stent implantation in left main trifurcations. (2009) (11)
- P2Y12 inhibitor monotherapy in patients undergoing percutaneous coronary intervention (2022) (11)
- Safety and effectiveness of the Catania Polyzene-F coated stent in real world clinical practice: 12-month results from the ATLANTA 2 registry. (2012) (11)
- Very late outcomes of drug-eluting stents: the 'catch-down' phenomenon. (2016) (11)
- Early Adverse Impact of Transfusion After Transcatheter Aortic Valve Replacement (2020) (11)
- Upcoming TAVI trials: rationale, design and impact on clinical practice. (2016) (11)
- Acute left atrial spontaneous echocardiographic contrast and suspicious thrombus formation following mitral regurgitation reduction with the MitraClip system. (2014) (11)
- Dual antithrombotic therapy for atrial fibrillation and PCI (2019) (10)
- Guided and unguided de-escalation from potent P2Y12 inhibitors among patients with ACS: a meta-analysis. (2021) (10)
- Evolution of stents: past, present and future (2009) (10)
- Effects of statin therapy on platelet reactivity after percutaneous coronary revascularization in patients with acute coronary syndrome (2017) (10)
- Triple therapy for atrial fibrillation and ACS with or without PCI: don't drop aspirin just yet. (2015) (10)
- Long‐term clinical and echocardiographic outcomes of Mitraclip therapy in patients nonresponders to cardiac resynchronization (2018) (10)
- TAVI as a threat to surgical practice: “much ado about nothing” or “the quiet before the storm”? (2010) (10)
- Efficacy and safety of aspirin for cardiovascular risk prevention in younger and older age: an updated systematic review and meta-analysis (2021) (10)
- Daytime sleepiness does not predict sleep apnoea in patients with coronary artery disease. (2011) (10)
- Impact of renal function on clinical outcomes after PCI in ACS and stable CAD patients treated with ticagrelor: a prespecified analysis of the GLOBAL LEADERS randomized clinical trial (2020) (10)
- Facilitated/Pharmaco-invasive Approaches in STEMI (2012) (10)
- Properties and clinical development of a novel coating technology: the poly[bis(trifluoroethoxy)phosphazene]. (2010) (10)
- Aspirin for primary prevention of cardiovascular disease (2010) (10)
- Is intravascular ultrasound beneficial for percutaneous coronary intervention of bifurcation lesions? Evidence from a 4314-patient registry (2010) (10)
- Procedural Management of Patients With Advanced Heart Failure Undergoing MitraClip Implantation (From the GRASP Registry). (2017) (10)
- Early results of MitraClip system implantation by real-time three-dimensional speckle-tracking left ventricle analysis (2016) (10)
- Aspirin for Primary Prevention of Cardiovascular Disease in the 21st Century: A Review of the Evidence. (2021) (10)
- [2021 ESC/EACTS Guidelines for the management of valvular heart disease]. (2022) (10)
- Head-to-head comparison of early vessel healing by optical coherence tomography after implantation of different stents in the same patient (2011) (10)
- Randomized trials of invasive cardiovascular interventions that include a placebo control: a systematic review and meta-analysis. (2020) (9)
- Bioabsorbable stents: only bad news? (2019) (9)
- Twelve-month outcomes after bioresorbable vascular scaffold implantation in patients with acute coronary syndromes. Data from the European Multicenter GHOST-EU Extended Registry. (2017) (9)
- Use of intravascular imaging in patients with ST-segment elevation acute myocardial infarction. (2020) (9)
- Residual platelet reactivity and outcomes with 5 mg prasugrel therapy in elderly patients undergoing percutaneous coronary intervention. (2014) (9)
- CHOICES IN ANTITHROMBOTIC MANAGEMENT FOR PATIENTS WITH ATRIAL FIBRILLATION UNDERGOING PERCUTANEOUS CORONARY INTERVENTION. QUESTIONS (AND ANSWERS) IN CHRONOLOGICAL SEQUENCE. (2020) (9)
- Incidence of Adverse Events at 3 Months Versus at 12 Months After Dual Antiplatelet Therapy Cessation in Patients Treated With Thin Stents With Unprotected Left Main or Coronary Bifurcations. (2019) (9)
- Triple antithrombotic therapy after ACS and PCI in patients on chronic oral anticoagulation: update (2018) (9)
- Prosthesis choice for transcatheter aortic valve replacement: Improved outcomes with the adoption of a patient-specific transcatheter heart valve selection algorithm. (2016) (9)
- Does the SYNTAX score get on your nerves? Practical considerations on how and when avoiding it to maximize its usefulness with no waste of time. (2012) (9)
- Impact of structural features of very thin stents implanted in unprotected left main or coronary bifurcations on clinical outcomes (2019) (9)
- Impact of gastric acid-suppressing therapies on platelet reactivity in patients with coronary artery disease treated with clopidogrel: results of a pharmacodynamic study. (2011) (9)
- Defining Device Success for Percutaneous Coronary Intervention Trials: A Position Statement from the European Association of Percutaneous Cardiovascular Interventions of the European Society of Cardiology. (2019) (8)
- Antithrombotic therapy following transcatheter aortic valve implantation: what challenge do we face? (2016) (8)
- ABCD‐GENE Score and Clinical Outcomes Following Percutaneous Coronary Intervention: Insights from the TAILOR‐PCI Trial (2022) (8)
- Risk stratification after ST-segment elevation myocardial infarction (2016) (8)
- Meta-analysis Comparing Outcomes of Self-Expanding Versus Balloon-Expandable Valves for Transcatheter Aortic Valve Implantation. (2020) (8)
- New insights on acute expansion and longitudinal elongation of bioresorbable vascular scaffolds in vivo and at bench test: A note of caution on reliance to compliance charts and nominal length (2015) (8)
- Impacto del tratamiento adyuvante con cilostazol comparado con dosis altas de mantenimiento de clopidogrel en pacientes con diabetes mellitus y respuesta subóptima (2012) (8)
- One-year outcomes after Absorb bioresorbable vascular scaffold implantation in routine clinical practice. (2016) (8)
- Risk Stratification for Percutaneous Coronary Intervention. (2016) (8)
- Early discharge in acute myocardial infarction after clinical and angiographic risk assessment (2008) (8)
- Transcatheter aortic valve implantation: what has been done and what is going to be done. (2010) (8)
- Impact of diabetes mellitus on long-term follow-up of percutaneous coronary intervention based on clinical presentation of coronary artery disease (2011) (8)
- Sirolimus versus paclitaxel-eluting stents in small coronary vessels: long-term outcomes from a single-center registry (2010) (8)
- Pre-Treatment With Oral P2Y12 Inhibitors in Acute Coronary Syndromes Without ST-Segment Elevation: The Saga Continues. (2019) (8)
- The Ultimaster® coronary stent system: state of the art. (2015) (8)
- Impact of Drug-Eluting Stents and Diabetes Mellitus in Patients With Coronary Bifurcation Lesions: A Survey From the Italian Society of Invasive Cardiology (2011) (8)
- Epidemiology and clinical impact of different anatomical phenotypes of the left main coronary artery (2011) (8)
- New-onset coronary aneurism and late-acquired incomplete scaffold apposition after full polymer jacket of a chronic total occlusion with bioresorbable scaffolds. (2015) (8)
- Stroke After Transcatheter Aortic Valve Replacement: A Multifactorial Phenomenon. (2019) (8)
- Usefulness of the logistic clinical SYNTAX score for predicting 1‐year mortality in patients undergoing percutaneous coronary intervention of the left main coronary artery (2013) (8)
- Evaluating the importance of sham-controlled trials in the investigation of medical devices in interventional cardiology. (2018) (7)
- P2Y12 Inhibitor or Aspirin Following Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: A Network Meta-Analysis. (2022) (7)
- State of the art: 40 years of percutaneous cardiac intervention. (2017) (7)
- Unmet needs of young interventional cardiologists: the EAPCI Young survey. (2013) (7)
- Joint EACVI HIT/EAPCI young survey/ESC CoT survey: training and education for 'multimodality imaging in structural interventions': the rise of a new sub-specialty? (2016) (7)
- Durability of transcatheter bioprosthetic aortic valves: the story so far. (2019) (7)
- Platelet Function Testing after Transcatheter Aortic Valve Implantation (2018) (7)
- Rapid Evaluation of Vessel HEaling After AngiopLasty (REVEAL) trial: rationale, objectives and design (2010) (7)
- The Conundrum Surrounding Racial Differences on Ischaemic and Bleeding Risk with Dual Anti-Platelet Therapy (2018) (7)
- Meta-analysis of everolimus-eluting stents versus first-generation drug-eluting stents in patients with left main coronary artery undergoing percutaneous coronary intervention. (2013) (7)
- Antithrombotic treatment in atrial fibrillation patients undergoing percutaneous coronary interventions: focus on stent thrombosis (2020) (7)
- Clinical outcomes of patients with diabetes mellitus treated with Absorb bioresorbable vascular scaffolds: a subanalysis of the European Multicentre GHOST‐EU Registry (2018) (7)
- Antiplatelet and Antithrombotic Therapy in Patients with Atrial Fibrillation Undergoing Coronary Stenting. (2017) (7)
- Lost in calculation: the clinical SYNTAX score goes logistic. (2012) (7)
- Prevalence of renal artery stenosis in patients undergoing cardiac catheterization. (2013) (7)
- Managing bioabsorbable vascular scaffold failure: combined scaffold restenosis and late-acquired coronary aneurysm treated with self-expandable stent. (2015) (7)
- Treatment of multilesion coronary artery disease with simultaneous drug-eluting and bare-metal stent implantation: clinical follow up and angiographic mid-term results. (2009) (7)
- Bioresorbable Scaffolds: Clinical Outcomes and Considerations. (2016) (7)
- Impact of adjunctive cilostazol therapy versus high maintenance dose of clopidogrel in suboptimal responders with diabetes mellitus. (2012) (7)
- Review and recommendations on the current practice of meta-analyses: a guide to appraise the evidence. (2014) (7)
- Antithrombotic pharmacotherapy after transcatheter aortic valve implantation: an update (2019) (6)
- Vascular response and healing profile of everolimus-eluting bioresorbable vascular scaffolds for percutaneous treatment of chronic total coronary occlusions: A one-year optical coherence tomography analysis from the GHOST-CTO registry. (2018) (6)
- Prevention of contrast-induced acute kidney injury in patients undergoing percutaneous coronary intervention. (2020) (6)
- Long-term outcomes comparison of different types of DES in elderly patients from a real-world experience. (2009) (6)
- Impact of moderate preoperative chronic kidney disease on mortality after transcatheter aortic valve implantation. (2015) (6)
- MitraClip Implantation for the Treatment of New-Onset Systolic Anterior Motion of the Mitral Valve After Transcatheter Aortic Valve Replacement. (2016) (6)
- Decision Analytic Markov Model Weighting Expected Benefits and Current Limitations of First-Generation Bioresorbable Vascular Scaffolds: Implications for Manufacturers and Next Device Iterations (2018) (6)
- Suitability for elderly with heart disease of a QR code-based feedback of drug intake: Overcoming limitations of current medication adherence telemonitoring systems. (2020) (6)
- Relationship between Serum Inflammatory Biomarkers and Thrombus Characteristics in Patients with ST Segment Elevation Myocardial Infarction (2016) (6)
- Dual antiplatelet therapy in patients with diabetes mellitus: special considerations (2013) (6)
- Differences in coronary artery disease and outcomes of percutaneous coronary intervention with drug-eluting stents in women and men (2021) (6)
- An updated drug profile of ticagrelor with considerations on the treatment of patients with coronary artery disease and diabetes mellitus (2020) (6)
- Evolving paradigms in antithrombotic therapy for anticoagulated patients undergoing coronary stenting (2019) (6)
- Cost-effectiveness of the real-world use of drug-eluting stents at 9-month follow-up: results from the Sicilian DES Registry (2009) (6)
- Initial troponin level may predict thrombus burden in patients with acute coronary syndrome. Optical coherence tomography study. (2012) (6)
- Erratum to: Prevalence of renal artery stenosis in patients undergoing cardiac catheterization (2013) (6)
- Erratum to: 2021 ESC/EACTS Guidelines for the management of valvular heart disease. (2022) (6)
- Canakinumab for secondary prevention of coronary artery disease. (2021) (6)
- Effect size of ticagrelor over clopidogrel in the Platelet Inhibition and Patient Outcomes (PLATO) trial: from statistics to clinical judgment. (2012) (6)
- SYNTAX Score II predicts carotid disease in a multivessel coronary disease population. (2015) (6)
- Bridging antiplatelet therapy in patients requiring cardiac and non-cardiac surgery: from bench to bedside (2014) (6)
- Novel drugs for oral anticoagulation pharmacotherapy (2012) (6)
- Restenosis patterns after bioresorbable vascular scaffold implantation: Angiographic substudy of the GHOST‐EU registry (2018) (6)
- Early and long-term outlook of percutaneous coronary intervention for bifurcation lesions in young patients. (2013) (5)
- Unmasking psychological reasons of delay in acute coronary syndromes presentation during the COVID‐19 pandemic (2020) (5)
- Long-term effectiveness and safety of transcatheter closure of patent foramen ovale compared with antithrombotic therapy alone: a meta-analysis of six randomised clinical trials and 3,560 patients with reconstructed time-to-event data. (2018) (5)
- Dual antiplatelet therapy after percutaneous coronary intervention: entering the final chapter? (2019) (5)
- CABG versus PCI in diabetic patients with multivessel disease after risk stratification by the SYNTAX score: a pooled analysis of the SYNTAX and FREEDOM trials. (2014) (5)
- #SoMe for #IC: Optimal use of social media in interventional cardiology (2021) (5)
- Oral antithrombotic therapy after acute coronary syndromes: "dual antiplatelet" or "dual pathway"? (2017) (5)
- Revascularization of Unprotected Left Main Coronary Artery Disease: Implications of Evolving Data on Clinical Practice. (2016) (5)
- Dual antiplatelet therapy strategies and clinical outcomes for a polymer-free biolimus A9-coated stent. (2020) (5)
- A Risk-Scoring Model to Predict One-year Major Adverse Cardiac Events after Percutaneous Coronary Intervention (2015) (5)
- One-year outcomes in unselected patients treated with a thin-strut, platinum-chromium, paclitaxel-eluting stent: primary endpoint results from the TAXUS Element European post-approval surveillance study (TE-PROVE). (2015) (5)
- Sunday, 26 August 2012 (2012) (5)
- Accuracy of the PARIS score and PCI complexity to predict ischemic events in patients treated with very thin stents in unprotected left main or coronary bifurcations (2020) (5)
- Current status and ongoing development of reversing agents for novel oral anticoagulants (NOACs). (2013) (5)
- Very late thrombosis in acute myocardial infarction: drug-eluting versus uncoated stents. (2008) (5)
- Pretreatment with Antiplatelet Agents in the Setting of Percutaneous Coronary Intervention: When and Which Drugs? (2017) (5)
- Usefulness of 3D OCT to Diagnose a Noncircumferential Open-Cell Stent Fracture. (2016) (5)
- Long‐term clinical benefit of drug‐eluting stents over bare‐metal stents in diabetic patients with de novo left main coronary artery disease: Results from a real‐world multicenter registry (2009) (5)
- [Technical features of Absorb(TM) BVS implantation in the IT-DISAPPEARS registry]. (2014) (5)
- Guía ESC 2021 sobre la prevención de la enfermedad cardiovascular en la práctica clínica (2022) (5)
- Efficacy and safety of dual pathway inhibition in patients with cardiovascular disease: a systematic review and Meta-analysis. (2021) (5)
- Optical coherence tomography evaluation of the absorb bioresorbable scaffold performance for overlap versus non-overlap segments in patients with coronary chronic total occlusion: insight from the GHOST-CTO registry (2019) (5)
- Feasibility and predictors of early discharge after percutaneous edge-to-edge mitral valve repair (2017) (5)
- Risk stratification with the DAPT score: Carefully read the instructions and use as intended (2017) (4)
- Sex based analysis of the impact of red blood cell transfusion and vascular or bleeding complications related to TAVI - The TRITAVI-Women Study. (2021) (4)
- Transcatheter aortic valve durability and the dark side of Kaplan-Meier analysis. (2016) (4)
- A focused update on emerging prognostic determinants in distal left main percutaneous coronary intervention. (2012) (4)
- Timing, Selection, Modulation, and Duration of P2Y12 Inhibitors for Patients With Acute Coronary Syndromes Undergoing PCI. (2023) (4)
- Reference Renal Artery Diameter Is a Stronger Predictor of Contrast-Induced Nephropathy than Chronic Kidney Disease in Patients with High Cardiovascular Risk (2011) (4)
- Benefit of Extended Dual Antiplatelet Therapy Duration in Acute Coronary Syndrome Patients Treated with Drug Eluting Stents for Coronary Bifurcation Lesions (from the BIFURCAT Registry). (2021) (4)
- A post-hoc analysis of the CUSTOMIZE Registry on the differential impact of EuroSCORE and SYNTAX score in left main patients with intermediate Global Risk. (2011) (4)
- Management of adjunctive antithrombotic therapy in STEMI patients treated with fibrinolysis undergoing rescue or delayed PCI (2015) (4)
- Safety and efficacy of polymer‐free biolimus‐eluting stents versus ultrathin stents in unprotected left main or coronary bifurcation: A propensity score analysis from the RAIN and CHANCE registries (2020) (4)
- Strategies and Outcomes of Repeat Mitral Valve Interventions after Failed MitraClip Therapy (2017) (4)
- Unmet needs of young interventional cardiologists: proceedings from the 2nd summit of the European association of percutaneous cardiovascular interventions. (2014) (4)
- Left ventricular size predicts clinical benefit after percutaneous mitral valve repair for secondary mitral regurgitation: A systematic review and meta-regression analysis. (2019) (4)
- Pooling the Evidence at the Patient Level: End of the Bivalirudin Saga? (2020) (4)
- Atrial and ventricular function in thalassemic patients with supra-ventricular arrhythmias (2009) (4)
- Longitudinal elongation, axial compression, and effects on strut geometry of bioresorbable vascular scaffolds: insights from 2- and 3-dimensional optical coherence tomography imaging. (2015) (4)
- Twitterature. (2018) (4)
- New-generation drug-eluting stents for left main coronary artery disease according to the EXCEL trial enrollment criteria: Insights from the all-comers, international, multicenter DELTA-2 registry. (2019) (4)
- Risk stratification for secondary prevention with ticagrelor and aspirin: A closer look to patient subsets from the PEGASUS-TIMI 54 trial. (2015) (4)
- Early and mid-term clinical outcomes with the CATANIA coronary stent system vs. bare metal stents in patients with coronary artery disease. (2009) (4)
- Management issues of chronic therapy with non-vitamin K oral anticoagulants or antiplatelet agents: Different or alike? (2016) (3)
- Time for a debriefing: is there a future for bioresorbable scaffolds? (2018) (3)
- A Sex-Based Analysis From the RAIN-CARDIOGROUP VII Study (VeRy Thin Stents for Patients With Left MAIn or BifurcatioN in Real Life) on Left Main Stenting. (2020) (3)
- Diabetes mellitus: the scary killer haunting silently. (2010) (3)
- Efficacy and safety of dual-pathway inhibition in patients with cardiovascular disease: a meta-analysis of 49 802 patients from 7 randomized trials (2021) (3)
- Clinical Outcomes Following Intravascular Imaging-Guided Versus Coronary Angiography – Guided Percutaneous Coronary Intervention With Stent Implantation A Patients (2017) (3)
- Drug-eluting stents are not alike: does it matter? (2018) (3)
- Optical coherence tomography assessment of late intra-scaffold dissection: a new challenge of bioresorbable scaffolds. (2015) (3)
- Impact of Post-Procedural Change in Left Ventricle Systolic Function on Survival after Percutaneous Edge-to-Edge Mitral Valve Repair (2021) (3)
- Clinical development of selective anticoagulants: a state of the art. (2010) (3)
- Bleeding risk differences after TAVR according to the ARC-HBR criteria: insights from SCOPE 2. (2022) (3)
- Increasing CHADS₂ scores may attenuate the benefit of novel oral anticoagulants versus warfarin in reducing intracranial bleeding. (2012) (3)
- Appraising the contemporary role of aspirin for primary and secondary prevention of atherosclerotic cardiovascular events (2021) (3)
- Fate of Nonculprit Plaques in Patients With STEMI Undergoing Primary PCI Followed by Statin Therapy: A Serial Optical Coherence Tomography Analysis From the OCTAVIA Study. (2017) (3)
- Dual antiplatelet therapy duration after percutaneous coronary intervention in patients with indication to oral anticoagulant therapy. A systematic review and meta-analysis of randomized controlled trials. (2022) (3)
- Mechanisms of ST-segment elevation myocardial infarction in patients with atrial fibrillation, prior stenting and long-standing chronic coronary syndrome. (2020) (3)
- Determinants of Popularity and Natural History of Social Media Accounts in Interventional Cardiology. (2021) (3)
- Impact of Adjunctive Cilostazol Therapy Versus High Maintenance Dose of Clopidogrel in Suboptimal Responders With Diabetes Mellitus (2012) (3)
- Switching between P2Y12 inhibitors: Rationale, methods, and expected consequences. (2019) (3)
- ANMCO/SICI-GISE paper on antiplatelet therapy in acute coronary syndrome (2014) (3)
- Impact of the metal-to-artery ratio on clinical outcomes in left main and nonleft main bifurcation: insights the RAIN-CARDIOGROUP VII study (veRy thin stents for patients with left mAIn or bifurcatioN in real life) (2020) (3)
- Antithrombotic Strategies in Valvular and Structural Heart Disease Interventions: Current Status and Future Directions. (2013) (3)
- Bioresorbable Scaffolds and Plaque Regression: Raising the Bar in the Promised Land of Vascular Restoration Therapy. (2016) (3)
- Routine versus selective coronary artery bypass for left main coronary artery revascularization: the Appraise a Customized Strategy for Left Main Revascularization (CUSTOMIZE) study. (2011) (3)
- The "A, B, C" of multiple statistical methods for composite endpoints. (2020) (3)
- The Role of Antiplatelet Therapy in Patients With MINOCA (2022) (3)
- TCT-12 Impact of overlap on long-term clinical outcomes in patients undergoing everolimus-eluting bioresorbable vascular scaffolds implantation in routine clinical practice: insights from the European multicenter GHOST-EU registry (2015) (3)
- Initial experience of percutaneous coronary intervention in bifurcations with bioresorbable vascular scaffolds using different techniques--insights from optical coherence tomography. (2013) (3)
- Antiplatelet strategies for complex PCI. (2019) (3)
- When Less Becomes More: Insights on the Pharmacodynamic Effects of Aspirin Withdrawal in Patients With Potent Platelet P2Y12 Inhibition Induced by Ticagrelor (2020) (3)
- Trancatheter aortic valve implantation and mitral valve repair: two trains, two speeds. (2017) (3)
- Long-term antithrombotic pharmacotherapy following ST-elevation myocardial infarction. (2016) (3)
- Drug-Coated Stents Versus Bare-Metal Stents in Academic Research Consortium-Defined High Bleeding Risk Patients. (2020) (3)
- Composition, structure, and function of heart teams: a joint position paper of the ACVC, EAPCI, EACTS, and EACTA focused on the management of patients with complex coronary artery disease requiring myocardial revascularization. (2021) (3)
- Antithrombotic Pharmacotherapy in the Elderly: General Issues and Clinical Conundrums (2012) (3)
- Monday, 27 August 2012 (2012) (3)
- Impact of Culprit Plaque and Atherothrombotic Components on Incomplete Stent Apposition in Patients With ST-Elevation Myocardial Infarction Treated With Everolimus-Eluting Stents - An OCTAVIA Substudy. (2016) (3)
- Lipid Plaque Modification During Resorption of Absorb Bioresorbable Scaffold: Insights From Optical Coherence Tomography. (2018) (3)
- Aspects of Incomplete Stent Apposition (3)
- The DELTA 2 Registry (2021) (3)
- The Rapid Evaluation of Vessel Healing after Angioplasty (REVEAL) trial (2011) (2)
- How to Define Durability of Transcatheter and Surgical Bioprosthetic Aortic Valves: Facts and Misconceptions. (2020) (2)
- Contrast transesophageal echocardiography using the Acunav ultrasound catheter through the mouth way as a guide to percutaneous closure of patent foramen ovale. (2010) (2)
- Prevalence and morphological changes of carotid kinking and coiling in growth: an echo-color Doppler study of 2856 subjects between aged 0 to 96 years (2020) (2)
- TCT-419 Usefulness of a scoring system for predicting adverse cardiovascular events in patients undergoing everolimus-eluting bioresorbable scaffolds implantation: the PSP score. (2016) (2)
- Coronary revascularization strategies in patients with multivessel disease: is it all about diabetes? (2017) (2)
- Anti-inflammatory strategies for atherosclerotic artery disease (2022) (2)
- Optimal P2Y12 Inhibitor for Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction: Network Meta-Analysis in the Data-Free Zone: Do You Believe in Magic? (2016) (2)
- LONG-TERM PROGNOSIS OF PATIENTS WITH ACUTE CORONARY SYNDROME AND NON-OBSTRUCTIVE CORONARY ARTERY DISEASE (2011) (2)
- Effect of post‐procedural evidence‐based therapy on 2‐year prognosis after transcatheter mitral valve repair (2020) (2)
- Heparin versus bivalirudin for percutaneous coronary intervention: has the debate come to an end? (2017) (2)
- Embolization of Fractured Bioresorbable Scaffold Struts: Insights From 2- and 3-Dimensional Optical Coherence Tomography. (2016) (2)
- Cyphering the statistical and clinical significance of prasugrel in the TRITON-TIMI 38 trial. (2011) (2)
- Comparison of bioresorbable vs durable polymer drug-eluting stents in unprotected left main (from the RAIN-CARDIOGROUP VII Study) (2020) (2)
- Guía ESC/EACTS 2021 sobre el diagnóstico y tratamiento de las valvulopatías (2022) (2)
- New-Generation Drug-Eluting Stents for Left Main In-Stent Restenosis: The DELTA-2 Registry. (2018) (2)
- Early and Mid-Term Outcomes of Transcatheter Aortic Valve Replacement Using the New Generation Self-Expanding Corevalve Evolut R Device (2018) (2)
- Oral antithrombotic therapy for the prevention of recurrent cerebrovascular events. (2021) (2)
- Intolerance to aspirin in patients undergoing percutaneous coronary intervention in the setting of chronic coronary syndromes: perspectives from the ESC 2019 Chronic Coronary Syndromes guidelines. (2019) (2)
- Three-Dimensional Angle Assessment and Plaque Distribution Classification in Left Main Disease: Impact of Geometry on Outcome. (2015) (2)
- Armazones bioabsorbibles y regresión de la placa: subir el listón en la tierra prometida del tratamiento de restauración vascular (2016) (2)
- Trials of antithrombotic therapy in percutaneous coronary intervention: what evidence do we need to optimise our practice? (2018) (2)
- Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement. (2017) (2)
- Overlapping meta-analyses of bioresorbable vascular scaffolds versus everolimus-eluting stents: bringing clarity or confusion? (2016) (2)
- EARLY, LATE AND VERY LATE INCIDENCE OF BIORESORBABLE SCAFFOLD THROMBOSIS: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CLINICAL TRIALS AND OBSERVATIONAL REGISTRIES (2017) (2)
- CORRELATION BETWEEN THE VERIFYNOW P2Y12 ASSAY AND LIGHT TRANSMITTANCE AGGREGOMETRY TO MEASURE PLATELET P2Y12 RECEPTOR INHIBITION IN PATIENTS ON CLOPIDOGREL THERAPY (2010) (2)
- Assessing Patients for Left Main Percutaneous Coronary Intervention - Considerations and Practicalities of Risk Scores (2012) (2)
- IMPACT OF IRS-1 GENOTYPES ON PLATELET REACTIVITY AND CARDIOVASCULAR OUTCOMES IN TYPE 2 DIABETES MELLITUS PATIENTS WITH CORONARY ARTERY DISEASE (2010) (2)
- Multimodality Imaging - MRI - CT and Nuclear Cardiology: Magnetic Resonance Imaging (2012) (2)
- Dual antiplatelet therapy in patients at high bleeding risk: less is more-more or less. (2022) (2)
- Real‐world reasons and outcomes for 1‐month versus longer dual antiplatelet therapy strategies with a polymer‐free BIOLIMUS A9‐coated stent (2020) (2)
- Poster session Friday 13 December - PM: 13/12/2013, 14:00-18:00 * Location: Poster area (2013) (2)
- [Dual antiplatelet therapy in elderly patients with acute coronary syndrome: does age make the difference?] (2018) (2)
- Operator volume and mortality in percutaneous coronary intervention: a call for better competency metrics (2018) (1)
- Reply to the letter to the editor: the case for duplicate meta-analyses of patent foramen ovale closure in patients with cryptogenic stroke: more a ripple than a tsunami. (2014) (1)
- Residual mitral regurgitation impact on outcomes after mitraclip therapy: five-year follow-up from the GRASP registry (2021) (1)
- Bioresorbable Vascular Scaffolds as a Treatment Option for Left Main Lesions. (2017) (1)
- Long-Term Clinical Outcomes After Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting for Ostial / Midshaft Lesions in Unprotected Left Main Coronary Artery From the DELTA Registry A Multicenter Registry Evaluating Percutaneous Coronary Intervention Versus Coronary Artery Bypas (1)
- Self-apposing STENTYS® stent in acute myocardial infarction. (2014) (1)
- In-hospital outcomes in nonagenarian patients undergoing primary percutaneous coronary intervention. (2021) (1)
- Clinical pharmacotherapy and drug development for pulmonary arterial hypertension. (2011) (1)
- Stent Wars: Coated Stents Strike Back. (2020) (1)
- Contemporary issues on clopidogrel therapy: a critical appraisal (2009) (1)
- Monitoring antiplatelet therapy: where are we now? (2022) (1)
- TCT-178 Primary Endpoint Results from the TAXUS Element Post-Approval Surveillance Study (TE-PROVE): 1-Year Outcomes in Unselected Patients Treated With a Thin-Strut, Platinum-Chromium, Paclitaxel-Eluting Stent (2013) (1)
- Pursuing the goal to improve downstream myocardial tissue perfusion. (2008) (1)
- Long-term EXAMINATION of drug-eluting stents in acute myocardial infarction (2016) (1)
- The year in cardiology 2017: coronary interventions (2018) (1)
- Does the left circumflex coronary artery location impact on the success of chronic total occlusion recanalization? A single-center cohort study (2020) (1)
- Coronary Drug-eluting Stents (2008) (1)
- IMPACT OF CONCOMITANT AND STAGGERED PANTOPRAZOLE INTAKE ON PHARMACODYNAMIC EFFECTS INDUCED BY CLOPIDOGREL (2011) (1)
- AS-16: 18-Month Results from the ATLANTA FIM with a New Class of Stent: The CATANIA Coronary Stent with Polyzene-F (2009) (1)
- How true delivery profile diminution reduces vascular access challenges and complications. (2016) (1)
- Advances in the available pharmacotherapy for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation (2023) (1)
- Another Coronary Stent for Patients at High Bleeding Risk. (2021) (1)
- The usefulness of clinical indexes in the evaluation of cardiovascular risk in non cardiac surgery. (2006) (1)
- TCT-796 Comparison of Three Contemporary Surgical Scores For Predicting All-Cause Mortality Of Patients Undergoing Percutaneous Mitral Valve Repair With The MitraClip System: Insights From The Multicenter GRASP-IT Registry (2014) (1)
- Non-fatal MI as surrogate end point for all-cause or cardiovascular mortality (2022) (1)
- Ultrasound versus fluoroscopy-guided femoral access for percutaneous coronary intervention of chronic total occlusions: Insights from FOUND BLOOD CTO Registry. (2021) (1)
- TCT-401 Bioresorbable Scaffolds And Thrombosis: Insights From The GHOST-EU (Gauging coronary Healing with biOresorbable Scaffolding plaTforms in Europe) Registry. (2016) (1)
- Feasibility and Outcomes of Repeat Percutaneous Edge-to-Edge Mitral Valve Repair Procedures in Patients at High Risk for Surgery. (2018) (1)
- Bioresorbable scaffolds for calcified lesions: not a free lunch! (2016) (1)
- Revisiting the Network of Drug-Eluting Stent Trials: Bioresorbable Scaffolds Enter the Arena. (2016) (1)
- SERUM COTININE LEVELS ARE ASSOCIATED WITH INCREASED CLOPIDOGREL-INDUCED ANTIPLATELET EFFECTS IN PATIENTS WITH DIABETES MELLITUS AND CORONARY ARTERY DISEASE (2011) (1)
- Aspirin-free antithrombotic management following coronary stenting. Myth or reality? (2019) (1)
- Overcoming professional barriers encountered by women in interventional cardiology: an EAPCI statement. (2023) (1)
- Transesophageal echocardiography and transcranial color-Doppler: independent or complementary diagnostic tests for cardiologists in the detection of patent foramen ovale? (2008) (1)
- Pharmacology and Clinical Development of Factor XI Inhibitors (2023) (1)
- TCT-255 Effectiveness Of Preprocedural Statin Administration In Reducing Contrast−Induced Acute Kidney Injury: A Meta−Analysis Of Randomized Controlled Trials (2014) (1)
- Polymer-free biolimus-eluting stents or polymer-based zotarolimus-eluting stents for coronary bifurcation lesions. (2021) (1)
- Cyphering the mechanism of late failure of bioresorbable vascular scaffolds in percutaneous coronary intervention of the left main coronary artery. (2015) (1)
- The Sicilian Drug-eluting Stent Registry – Risk–Benefit and Cost-effectiveness Analyses of Drug-eluting Stents versus Bare-metal Stents (2008) (1)
- Patient focus in interventional cardiology: proceedings of the 2018 summit of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) - Nice, France, 20-21 June 2018. (2019) (1)
- Evolving Landscapes in Coronary Stents for Patients at High Bleeding Risk. (2021) (1)
- Hot topics in transcatheter aortic valve implantation. (2017) (1)
- P2Y12 Inhibitor Monotherapy: Considerations for Acute and Long-Term Secondary Prevention Post-PCI (2022) (1)
- Will ORBITA change my practice? ORBITA trial: Objective Randomised Blinded Investigation with optimal medical Therapy of Angioplasty in stable angina. (2018) (1)
- Progress with drug-eluting stents - are we done? (2019) (1)
- Targeting platelet nitric oxide resistance with ramipril: unraveling mechanisms of atherothrombotic risk reduction with angiotensin-converting enzyme inhibitors. (2012) (1)
- 351Impact of a decreasing pre-test probability on the performance of diagnostic tests for coronary artery disease (2019) (1)
- Pre-defining optimal C-arm position for TAVI with CT-scan using free software. (2013) (1)
- The optimal pharmacological formula for percutaneous coronary intervention (2011) (1)
- Contemporary Reviews in Cardiovascular Medicine Antithrombotic Therapy in Patients With Chronic Kidney Disease (2012) (1)
- Efecto de la técnica de implantación en los resultados en pacientes tratados con armazón bioabsorbible en diferentes escenarios clínicos (2019) (1)
- THROMBOTIC PROFILE ANALYSIS USING THROMBOELASTOGRAPHY IN END STAGE RENAL DISEASE PATIENTS UNDERGOING HEMODIALYSIS (2010) (0)
- CILOSTAZOL THERAPY ACHIEVES GREATER P2Y12 INHIBITORY EFFECTS COMPARED TO HIGH CLOPIDOGREL MAINTENANCE DOSING IN SUBOPTIMAL CLOPIDOGREL RESPONDERS WITH DIABETES MELLITUS (2010) (0)
- Diuresis-matched versus standard hydration in patients undergoing percutaneous cardiovascular procedures: meta-analysis of randomized clinical trials. (2023) (0)
- TCT-224 Predictors and safety of next-day discharge after minimalistic transfemoral aortic valve implantation (2018) (0)
- Bivalirudin and argatroban (2018) (0)
- Percutaneous Edge-to-Edge Mitral Valve Repair with the Mitraclip System in Barlow’s Disease (2020) (0)
- EuroIntervention and EuroPCR 2019 - together embodying the spirit of interventional cardiology. (2019) (0)
- Emerging strategies for rapid reversal of anticoagulation in patients undergoing catheter-based interventions: aptamers enter the RADAR. (2014) (0)
- The inflammatory abdominal aortic aneurysm and coronary artery disease. Case report and review. (2006) (0)
- 955 Echo-TDI evaluation of left atrial function in patiens with major thalassemia (2006) (0)
- Sirolimus- vs. paclitaxel-eluting stents in patients undergoing off-label percutaneous coronary intervention. (2010) (0)
- Renal Artery Diameter Is a Stronger Predictor of Contrast-Induced Nephropathy than Chronic Kidney Disease in Patients with High Cardiovascular Risk (2011) (0)
- 806 Scout post-PCI instantaneous wave-free ratio as a driver of functional complete (2021) (0)
- 807 Wellens syndrome: a rare entity not to underestimate (2021) (0)
- Wearable cardioverter-defibrillator in patients at risk of sudden cardiac death: consensus document from Kalarus et al. contradicts current guideline recommendations-Authors' reply. (2020) (0)
- No Benefit of Different Drug or Design on Clinical Outcomes of First-Generation Polymeric Scaffolds: Does Resorption Time Play a Better Role? (2017) (0)
- [Antiplatelet and anticoagulant therapy in elderly patients]. (2011) (0)
- Coronary Artery Disease Impact of Insulin Receptor Substrate-1 Genotypes on Platelet Reactivity and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease (2011) (0)
- Sunday, 18 July 2010 (2010) (0)
- The Need to Standardize Our Language Around Dual Antiplatelet Therapy-A Call to Action. (2022) (0)
- Guía ESC 2019 sobre el diagnóstico y tratamiento de los síndromes coronarios crónicos (2020) (0)
- [Recent advances in the knowledge of coronary flow disturbances after percutaneous coronary intervention]. (2009) (0)
- Transcatheter Therapy for Aortic Stenosis: A Review of the Literature (2018) (0)
- The EuroIntervention health check 2019. (2019) (0)
- Optical coherence tomography to detect the age of thrombus in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention (2013) (0)
- Long-Term P2Y12 Inhibitor or Aspirin as Single Antiplatelet Therapy in Patients With Previous Percutaneous Coronary Intervention. (2023) (0)
- Reply: Short Duration of DAPT vs De-Escalation After Percutaneous Coronary Intervention for Acute Coronary Syndromes. (2022) (0)
- Therapeutic uncertainties: first finding of atrial fibrillation in acute coronary syndrome (2022) (0)
- Antiplatelet therapy after noncardioembolic ischemic stroke or transient ischemic attack (2022) (0)
- Radial access for acute coronary syndromes: case closed? (2016) (0)
- Shortening Dual Antiplatelet Therapy Duration in High-Risk Patients Undergoing Percutaneous Coronary Intervention (2023) (0)
- Davide Capodanno MD PhD. (2017) (0)
- Artery Disease in the Contemporary Era : Review of the Evidence and Practice Guidelines Pretreatment With Antiplatelet Drugs in Invasively Managed Patients With Coronary (0)
- The year in review 2019: Coronary interventions. (2020) (0)
- TCT-172 Everolimus-Eluting Bioresorbable Vascular Scaffolds for Percutaneous Treatment of Chronic Total Coronary Occlusions: 1 Year Optical Coherence Tomography findings from the GHOST-CTO Registry (2017) (0)
- Research Correspondence Impact of Gastric Acid-Suppressing Therapies on Platelet Reactivity in Patients With Coronary Artery Disease Treated With Clopidogrel (2011) (0)
- PCR e-Course: reshaping education in exceptional circumstances. (2020) (0)
- ocal Delivery Versus Intracoronary Infusion f Abciximab in Patients With Acute oronary Syndromes (0)
- 339 INTRAVENOUS CANGRELOR VERSUS ORAL TICAGRELOR IN PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION UNDERGOING PRIMARY PERCUTANEOUS CORONARY INTERVENTION: A PROPENSITY SCORE-MATCHED ANALYSIS (2022) (0)
- One-Year Coverage by Optical Coherence Tomography of a Bioresorbable Scaffold Neocarina: Is It Safe to Discontinue Dual-Antiplatelet Therapy? (2015) (0)
- Reply (2022) (0)
- Will ABSORB III change my practice? Everolimus-eluting bioresorbable scaffolds for coronary artery disease. (2016) (0)
- Usefulness of the logistic Clinical SYNTAX score for predicting 1-year mortality in patients undergoing percutaneous coronary intervention of the left main coronary artery (2013) (0)
- Long term results of unprotected left main percutaneous coronary intervention with DES versus BMS. (2009) (0)
- TCT-280 Drug−Coated Balloon Versus Drug−Eluting Stent For In−Stent Restenosis: A Meta−Analysis Of Randomized Controlled Trials (2014) (0)
- Association of guideline-directed medical therapy adherence with outcomes after fractional flow reserve-based deferral of revascularization. (2022) (0)
- Revascularization strategies versus optimal medical therapy in chronic coronary syndrome: A network meta-analysis. (2022) (0)
- Antithrombotic Strategies in Valvular and Structural Heart Disease Interventions (2013) (0)
- MID-TERM CLINICAL OUTCOME OF CATANIA™ CORONARY STENT SYSTEM WITH NANOTHIN POLYZENE®-F IN A REAL WORLD UNSELECTED POPULATION: PRELIMINARY RESULTS: I2 POSTER CONTRIBUTIONS (2010) (0)
- Adaptations of the Synergy Between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery Score and Proofs of Concept (2016) (0)
- Response to: SYNTAX score and left main stenting: Do we need clinical variables to predict outcomes? (2010) (0)
- The EAPCI and continuing education for Fellows. (2015) (0)
- Impact of the ISCHEMIA randomized clinical trial on the management of patients with chronic coronary syndrome (2022) (0)
- TCT-171 Optical Coherence Tomography evaluation of the Absorb bioresorbable scaffold performance for overlap versus non-overlap segments in patients with coronary chronic total occlusion: insights from the GHOST-CTO registry (2017) (0)
- Safe femoral access for STEMI patients and mortality in the new decade: Back to the future? (2020) (0)
- Role of continuous glucose monitoring in diabetic patients at high cardiovascular risk: an expert-based multidisciplinary Delphi consensus (2022) (0)
- Mid-term clinical outcome of CATANIA coronary stent system with nanothin Polyzene-F in a real-world unselected population (2009) (0)
- 518 DUAL ANTIPLATELET THERAPY DE-ESCALATION MODALITIES IN ACUTE CORONARY SYNDROME PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION (2022) (0)
- Clinical Pharmacokinetics and Pharmacodynamics of CSL112 (2023) (0)
- Permanent pacemaker implantation and left bundle branch block with self-expanding valves - a SCOPE 2 subanalysis. (2022) (0)
- Antithrombotic therapy after transcatheter aortic valve implantation (2022) (0)
- EuroIntervention: moving forward. (2020) (0)
- Acute and subacute scaffold thrombosis (2017) (0)
- 372 PLATYPNEA-ORTHODEOXIA SYNDROME CAUSING POSITIONAL DYSPNEA AND ARTERIAL DESATURATION IN AN ELDERLY WOMAN: A CASE REPORT (2022) (0)
- Progresses in interventional cardiology: focus on patent foramen ovale, coronary intervention, antithrombotic pharmacology and more (2013) (0)
- TCT-437 Determinants and Long-Term Outcomes of Largely Uncovered Struts in Thin-Strut Drug-Eluting Stents Assessed by Optical Coherence Tomography: A TRANSFORM-OCT Substudy (2021) (0)
- IMPACT OF CANGRELOR ON MULTIPLE PLATELET SIGNALING PATHWAYS IN PATIENTS WITH CORONARY ARTERY DISEASE (2011) (0)
- P1671Impact of chronic kidney disease on mitral valve repair with the mitraclip system: one-year outcomes frome the GRASP registry stratified by left ventricular dysfunction (2018) (0)
- Characterization of actionable bleeding and thrombotic risk trade-offs in patients undergoing percutaneous coronary intervention (2021) (0)
- Revascularization strategies versus optimal medical therapy in chronic coronary syndrome: a systematic review and network meta-analysis (2022) (0)
- Current management and screening of peripheral and coronary artery disease in people with diabetes mellitus in Europe. The PADDIA/CADDIA survey. (2022) (0)
- TCT-629 A simple risk model to refine the predictive ability of the STS score for the estimation of early and mid-term mortality in patients undergoing MitraClip implantation. (2016) (0)
- Incidence, mechanisms and clinical impact of largely uncovered struts in current generation drug-eluting-stents: insight from the TRANSFORM-OCT Study (2020) (0)
- Triaging patients with left main disease after the EXCEL and NOBLE trials: the everlasting saga of coronary artery bypass grafting and percutaneous coronary intervention. (2017) (0)
- Reply to the letter: 'the effects of CPAP in OSAS patients with coronary artery disease: still not completely understood'. (2015) (0)
- Conclusion (0)
- Bioresorbable vascular scaffold in patients with complex coronary artery disease. (2016) (0)
- Reflections after TWILIGHT study: a new era in secondary prevention without aspirin? (2021) (0)
- Reply: Short Duration of DAPT vs De-Escalation After Percutaneous Coronary Intervention: Only These 2 Options? (2022) (0)
- Incidence and Predictors of Early and Late Mortality After Transcatheter Aortic Valve (2011) (0)
- Cardioleaks. (2019) (0)
- P3690Impact of high on-treatment platelet reactivity on 1-year clinical outcome in elderly patients with NSTE-ACS undergoing percutaneous coronary intervention- insights from the GEPRESS study (2017) (0)
- CD4+ lymphocyte count predicts recurrent thrombotic events in HIV-infected patients with acute coronary syndromes (2013) (0)
- One and twelve month safety and efficacy outcomes of patients undergoing edge-to-edge percutaneous mitral valve repair: the GRASP registry (2013) (0)
- 4289Clinical outcomes of percutaneous mitral valve repair in secondary mitral regurgitation: a systematic review and meta-analysis (2019) (0)
- Response to Letter Regarding Article, “Pharmacodynamic Effects of Different Aspirin Dosing Regimens in Type 2 Diabetes Mellitus Patients With Coronary Artery Disease” (2011) (0)
- Digital speakers in the digital era. (2017) (0)
- Abstract 13567: Impact of Chronic Kidney Disease on Clopidogrel-Induced Antiplatelet Effects in Non-Diabetic Patients with Coronary Artery Disease (2012) (0)
- Perioperative management of oral antiplatelet therapy in patients with coronary stents undergoing surgery (2013) (0)
- Atrial Fibrillation on Vitamin K Antagonist Undergoing Primary Percutaneous Coronary Intervention for Acute ST-Elevation Myocardial Infarction (2017) (0)
- Interventions at High Bleeding Risk in Multiple Surgical and Invasive Scenarios Type of surgery Cardiac surgery (0)
- Long-term monotherapy with ticagrelor after coronary stenting: the GLOBAL LEADERS study (2020) (0)
- [Antithrombotic therapy in patients undergoing transcatheter aortic valve implantation: the quest for the Holy Grail]. (2016) (0)
- Wearable cardioverter-defibrillator to reduce the transient risk of sudden cardiac death in coronary artery disease: Authors' reply. (2020) (0)
- TCT-547 Sham-Controlled Trials of Invasive Cardiovascular Interventions: A Systematic Review and Meta-Analysis (2019) (0)
- TCT-226 Application of the Academic Research Consortium High Bleeding Risk Trade-Off Model in an All-Comers Global Registry of Percutaneous Coronary Intervention (2021) (0)
- Reply: plaque rupture in stable coronary artery disease. (2015) (0)
- Late Self-Apposition With One-Year Persisting Uncoverage of Malapposed Bioresorbable Polymeric Struts. (2017) (0)
- Impact of P2Y12-mediated platelet reactivity on myocardial perfusion of patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a cardiac magnetic resonance study (2015) (0)
- TCT-380 Comparison Among Different Preventive Strategies for Contrast-Induced Acute Kidney Injury in Patients Undergoing Coronary Catheterization: A Hierarchical Bayesian Network Meta-Analysis of Randomized Trials (2015) (0)
- TCT-156 Patterns of Therapy Cessation in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: Insights From the AVIATOR-2 International Registry (2019) (0)
- Left Atrial Decompression Using Unidirectional Left-to-Right Interatrial Shunt (2017) (0)
- BVS in patients with complex coronary artery disease. (2016) (0)
- Platelets and Thrombosis Impact of Chronic Kidney Disease on Platelet Function Profiles in Diabetes Mellitus Patients With Coronary Artery Disease Taking Dual Antiplatelet Therapy (0)
- [Management of antithrombotic therapy in patients with bleeding after percutaneous coronary intervention]. (2020) (0)
- Cardiac and Noncardiac Surgery Management of Antiplatelet Therapy in Patients With Coronary Artery Disease Requiring (2013) (0)
- [Bleeding risk in patients undergoing percutaneous coronary intervention: how to define, identify and treat high-risk patients]. (2020) (0)
- Relationship between macrophage distribution and plaque type as assessed by optical coherence tomography in culprit vessel of acute myocardial infarction (2013) (0)
- INTER-ASSAY AGREEMENT TO DEFINE INADEQUATE CLOPIDOGREL RESPONSE (2010) (0)
- Survival post transcatheter aortic valve implantation for aortic stenosis: the STT score. derivation and external validation (2014) (0)
- Is the Metallic Stent a Safe Treatment for Bioresorbable Scaffold Failure?: Insights From Optical Coherence Tomography. (2016) (0)
- Determinants and long‐term outcomes of largely uncovered struts in thin‐struts drug‐eluting stents assessed by optical coherence tomography (2022) (0)
- 508 ELIGIBILITY TO DUAL PATHWAY INHIBITION THERAPY IN PATIENTS WITH CORONARY OR PERIPHERAL ARTERY DISEASE (2022) (0)
- Fate of Coronary Chronic Total Occlusion Recanalization via Subintimal Tracking With Bioresorbable Vascular Scaffolds: A Temporary Cage for a Permanent New Lumen? (2015) (0)
- What is the future role of cerebral embolic protection in transcatheter aortic valve implantation? (2022) (0)
- Composition, structure, and function of heart teams: a joint position paper of the ACVC, EAPCI, EACTS, and EACTA focused on the management of patients with complex coronary artery disease requiring myocardial revascularization. (2021) (0)
- Reply: Validity of Randomized Trials Comparing Radial Versus Femoral Access in Acute Coronary Syndrome. (2016) (0)
- Performance of Thin-Strut Stents in Non-Left Main Bifurcation Coronary Lesions: A RAIN Subanalysis. (2021) (0)
- Contrast-induced nephropathy in acute coronary syndromes: Causal or casual? (2022) (0)
- 122 A SWORD IN THE STONE - A STEMI AFTER MIAVR (2022) (0)
- Thrombosis and haemostasis : Biological considerations and pharmacological issues (2017) (0)
- DOACs and rheumatic valvulopathy: always a red light? (2023) (0)
- Culprit Lesions Phenotypes in ST-Segment Elevation Acute Coronary Syndromes: A Call for Precision Medicine. (2022) (0)
- To unsubscribe, please click here. (2018) (0)
- Bioprosthetic valves for transcatheter aortic valve replacement. (2014) (0)
- Triple Therapy, Dual Therapy, and Modulation of Anticoagulation Intensity. (2021) (0)
- CORONARY ARTERY DISEASE Original Studies A Multidisciplinary Consensus Document on Follow-Up Strategies for Patients Treated With Percutaneous Coronary Intervention (2015) (0)
- AS-40: Clinical Outcome of CATANIA Coronary Stent System with NanoThin Polyzene-F in a Real-World Unselected Population: Assessment of the ATLANTA-II Study (2010) (0)
- THE ROLE OF FEMALE SEX IN THE CONTEMPORARY TREATMENT OF THE LEFT MAIN CORONARY ARTERY INSIGHTS FROM THE W– DELTA (WOMEN– DRUG ELUTING STENT FOR LEFT MAIN CORONARY ARTERY DISEASE) REGISTRY (2013) (0)
- Risk Stratification Approach to Multivessel Coronary Artery Disease (2016) (0)
- 47 UNDER THE BRIDGE: OFF-LABEL CANGRELOR FOR PCI PATIENTS UNDERGOING NON CARDIAC SURGERY (2022) (0)
- Impact of In-Stent Tissue Type on Periprocedural Myocardial Infarction and 2-Year Clinical Outcomes After Treatment of€Coronary Artery Restenosis (0)
- Transcranial color Doppler is essential to quantify right to left shunt severity (2009) (0)
- 647 COMPLEX PERCUTANEOUS CORONARY INTERVENTION IN HIGHT BLEEDING AND THROMBOTIC RISK PATIENT: WHICH ANTITHROMBOTIC THERAPY? (2022) (0)
- 735 Myocardial ischaemia: not just about obstructive coronary arteries (2021) (0)
- Antithrombotic strategy variability in atrial fibrillation and obstructive coronary disease revascularised with percutaneous coronary intervention: primary results from the AVIATOR 2 international registry. (2022) (0)
- Rapid Evaluation of Vessel hEaling After angiopLasty (REVEAL) study: an optical coherence tomography comparative study versus bare and drug-eluting stent at 7 and 30 days (2009) (0)
- Conclusion: What We Learnt from Clinical Trials and Real‐World Experience (2021) (0)
- Ventricular arrhythmias before and after transcatheter aortic valve implantation (2013) (0)
- Acute coronary syndrome with spontaneous coronary artery dissection: which therapeutic option for a different pathophysiology? (2020) (0)
- Angiographic or Functional Success?: Rethinking the Goal of Percutaneous Coronary Intervention. (2018) (0)
- [Clinical decision making in left main coronary artery disease revascularization: the past, present and future]. (2012) (0)
- Mechanism of action and clinical development of ticagrelor, a novel platelet (2010) (0)
- Effect of implantation technique on outcomes in patients receiving bioresorbable scaffolds in various clinical scenarios (2019) (0)
- One-year clinical outcomes from the ATLANTA first-in-man with a new class of stent: the CATANIA coronary stent with Polyzene-F (2009) (0)
- 650 LARGE THROMBUS BURDEN: IS THERE STILL A ROLE FOR GPI? (2022) (0)
- Multimodality imaging methods and systemic biomarkers in classical low-flow low-gradient aortic stenosis: Key findings for risk stratification (2023) (0)
- Factor XI Inhibitors in Early Clinical Trials: A Meta-analysis (2022) (0)
- Transcatheter Therapy for Mitral Regurgitation: A Review of the Literature (2018) (0)
- Preoperative fibrinogen and morbidity in patients with residual platelet inhibition undergoing off-pump coronary artery bypass grafting: cause or effect? (2014) (0)
- TCT-580 Two-Year Real-World Outcomes in 1014 Patients Treated With the Thin-Strut, Platinum-Chromium, Paclitaxel-Eluting TAXUS Element® Stent: Results From the TE-PROVE European Registry (2014) (0)
- Impact of the ISCHEMIA trial on the role of noninvasive diagnostic pathways in patients with chronic coronary syndrome. (2023) (0)
- Reply: Bioresorbable Everolimus-Eluting Vascular Scaffold for Long Coronary Lesions: A Subanalysis of the International, Multicenter GHOST-EU (Gauging coronary Healing with bioresorbable Scaffolding plaTforms in EUrope) Registry. (2017) (0)
- Beyond the impact factor: may we have your attention, please? (2018) (0)
- Update on clinical evidence (Part II): A summary of the main post market studies (2016) (0)
- Approaches to de-escalation of antiplatelet treatment in stabilized post-myocardial infarction patients with high ischemic risk (2022) (0)
- Early P2Y12 Inhibitors Escalation in Primary PCI Patients: Insights from the RENOVAMI Registry (2018) (0)
- Antithrombotic Management in AF Patients Following Percutaneous Coronary Intervention: A European Perspective (2023) (0)
- Unusual interatrial membrane in the left atrium: A newer obstacle for transseptal‐based percutaneous mitral valve repair techniques? (2017) (0)
- Predicting acute adverse contrast mean reactions following cardiac catheterization: a complex undertaking. (2019) (0)
- Reversal and removal of oral antithrombotic drugs in patients with active or perceived imminent bleeding. (2023) (0)
- storm ' ' ? ado about nothing ' ' or ' ' the quiet before the TAVI as a threat to surgical practice : ' ' much (0)
- Defibrillators for prevention from sudden cardiac death: is it that easy?-Authors' reply. (2020) (0)
- Management of Patients after Acute Coronary Syndrome (2014) (0)
- Incidence and Predictors of Early and Late Mortality After Transcatheter Aortic Valve Implantation in 663 Patients With Severe Aortic Stenosis and predictors (2011) (0)
- [Pharmacological strategy pre- and post-percutaneous coronary intervention in patients with acute coronary syndrome on oral anticoagulation therapy]. (2020) (0)
- [Dual antiplatelet therapy (DAPT) after acute coronary syndrome: short DAPT versus de-escalation]. (2022) (0)
- [Management of severe stenosis controversies and promises]. (2011) (0)
- Surgical thromboembolectomy for a massive pulmonary embolism after several venous thromboembolic episodes caused by congenital antithrombin III deficiency. (2011) (0)
- Tratamiento antitromb�tico sin �cido acetilsalic�lico tras implante de stent: �mito o realidad? (2019) (0)
- PRETREATMENT WITH P 2 Y 12 INHIBITORS IN PATIENTS WITH STABLE CORONARY INTERVENTION UNDERGOING PERCUTANEOUS CORONARY INTERVENTION Should Clopidogrel Be Given Before Percutaneous Coronary Intervention ? (2016) (0)
- Epidemiology and clinical impact of different anatomical phenotypes of the left main coronary artery Davide CapodannoMaria E. Di SalvoDario SeminaraAnna Caggegi • Giombattista BarranoFrancesco TagliareniFabio DipasquaCorrado Tamburino (2011) (0)
- Planning Coronary Intervention: The “Golden Rules”—Patient Checklist and Troubleshooting (2018) (0)
- Antithrombotic treatment strategies in patients with established coronary atherosclerotic disease: 2022 joint clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI), Association for Acute CardioVascular Care (ACVC) and European Association of Pr (2023) (0)
- TCT-495 Drug-Eluting Stent and Drug-Coated Balloon for Coronary In-Stent Restenosis: A Pair-Wise Meta-Analysis of Randomized Trials Implemented with Trial Sequential Analysis (2015) (0)
- Response to Letter Regarding Article, “Antithrombotic Therapy in Patients With Chronic Kidney Disease” (2012) (0)
- TCT-493 Interventional Strategies for Coronary In-Stent Restenosis: A Hierarchical Bayesian Network Meta-Analysis of Randomized Trials (2015) (0)
- 463 WOVEN CORONARY ARTERY AN INCIDENTAL FINDING (2022) (0)
- TCT-252 Preprocedural Statin Administration Benefit According To Baseline Renal Function: A Meta−Analysis Of Randomized Controlled Trials (2014) (0)
- Cerebrovascular disease—what is the role of dual antiplatelet therapy for the prevention and treatment of ischemic stroke? (2021) (0)
- EVALUATION OF THE ACADEMIC RESEARCH CONSORTIUM HIGH BLEEDING RISK DEFINITION IN PATIENTS TREATED WITH DRUG-COATED STENTS AND BARE-METAL STENTS FROM THE LEADERS FREE I & II TRIALS (2020) (0)
- 289 DIAGNOSTIC PATHWAY OF PATIENTS WITH CHRONIC CORONARY SYNDROME AFTER THE ISCHEMIA TRIAL PUBLICATION (2022) (0)
- P972A subgroup analysis from the RAIN-CARDIOGROUP VII study: incidence of adverse events after DAPT cessation in patients treated with ultrathin stents in ULM or coronary bifurcations (2019) (0)
- Impact of scaffold overlapping on 1-year clinical outcomes in patients undergoing everolimus-eluting BRS in rutine clinical practice. Insights from GHOST-EU registry (2015) (0)
- Dual antiplatelet therapy after acute coronary syndromes: no time for a CHANGE. (2017) (0)
- OP-EUPA180177 1..27 (2018) (0)
- Use of clopidogrel, aspirin and oral anti-coagulant therapy in patients undergoing percutaneous coronary intervention: a meta-analysis of randomized controlled trials and adjusted observational result (2014) (0)
- Bridging therapy with low molecular weight heparin in patients with coronary stents undergoing surgery (2013) (0)
- [The PRAMI study]. (2014) (0)
- IMPACT OF PENTOXIFYLLINE ON PLATELET FUNCTION PROFILES IN PATIENTS WITH TYPE 2 DIABETES MELLITUS WITH CORONARY ARTERY DISEASE ON DUAL ANTIPLATELET THERAPY (2011) (0)
- Incidence and Predictors of Early and Late Mortality After Transcatheter Aortic Valve Implantation in 663 Patients With Severe Aortic Stenosis and (2011) (0)
- TCT CONNECT-405 Use of Intravascular Imaging in Patients With ST-Segment Elevation Acute Myocardial Infarction (2020) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Davide Capodanno?
Davide Capodanno is affiliated with the following schools:
